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In response to antigenic stimulation and extrinsic cytokine signals CD4+ T cells 
differentiate into specialized effector T helper (Th) cell subsets. Regulation of 
plasticity between these CD4+ T-cell lineages is critical for immune homeostasis 
and prevention of autoimmune diseases. However, the factors that regulate 
lineage stability are largely unknown. In Chapter 2, retinoic acid (RA), the active 
metabolite of vitamin A, is shown to regulate the stability of T helper 1 (Th1) 
cells, traditionally considered the most phenotypically stable CD4+ T cell subset. 
Signaling through RA receptor α (RARα) sustains stable expression of Th1 
lineage specifying genes, as well as repression of genes that instruct Th17 cell 
fate.  RA signaling is shown to be critical for limiting Th1 cell conversion into 
Th17 effectors and for preventing pathogenic Th17 responses in vivo.  These 
findings identify RA/RARα as a key component of the regulatory network 
governing maintenance and plasticity of Th1 cell fate and define a new pathway 
for the development of pathogenic Th17 cells.  The molecular mechanisms 
underlying regulation of Th1 plasticity depend on the ability of RARα to recruit 
p300 to cis regulatory enhancers at key Th1 defining genes.  Chapter 3 
expands on these findings and examines a global role for RARα in the 
regulation of enhancers in both Th1 and Th17 cells.  Strikingly, RARα is shown 
to be the dominant regulator of enhancer activation in Th1 cells.  Comparison of 
RARα bound enhancers in T helper cell subsets reveal lineage specific RARα 
bound genes and provide a mechanistic basis for the cell context dependent 
effects of RA on T helper cell fate.  Collectively, the data identify a fundamental 
role for RA synthesis and signaling in the epigenetic regulation of T helper cell 
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fate and suggest a broader role for RARα in the regulation of enhancers outside 
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CHAPTER 1: Epigenetic and transcriptional regulation of T helper cell 
fate: a role for retinoic acid 
 
The crosstalk between the innate and adaptive arms of the immune system 
creates an inflammatory microenvironment that ultimately controls the fate of 
responding T cells. Naïve CD4+ T-cells circulate between blood and the 
lymphatic system, passing through secondary lymphoid organs where they 
encounter antigen presenting cells (APCs) bearing antigens.  Encounters with 
cognate antigens within these environments drive differentiation of naïve CD4+ 
T cells into functionally distinct effector T helper (Th) and regulatory T cell 
(Treg) subsets. The APC along with other innate immune cells present at the 
site of T cell priming provide extracellular signals through cytokines and other 
mediators. These activate complex networks of transcription factors (TFs) in a 
spatiotemporal manner to drive coordinated changes in gene expression and 
direct the differentiation program towards a specific T cell lineage. Appropriate 
lineage specification of naïve CD4+ T cells is critical to a successful immune 
response. Lineage commitment and maintenance of cell fate involves the 
interplay of multiple transcription factors and epigenetic modifications which 
together direct cell-specific gene expression programs (Tsankov et al., 2015). 
Although traditionally thought of as distinct lineages, over the last few years 
there has been increasing appreciation of developmental flexibility between T 
helper cell subsets both in vitro and in vivo. Dysregulated CD4+ T cell 
responses underlie the pathogenesis of allergic and autoimmune diseases, and 
thus underscore the importance of understanding the pathways that drive 
lineage specification and plasticity. 
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Transcriptional regulation of T helper cell specification 
Cytokines direct T helper cell specification, and in turn T helper cell subsets 
produce distinct patterns of cytokines which allow T cells to recruit different cells 
with appropriate effector functions, tailored to the pathogen. Th1 cells produce 
Interferon-γ (IFN-γ) and are important for host resistance to intracellular 
pathogens. Th2 cells produce Interleukin-4 (IL-4), IL-13 and IL-15 and help to 
control parasitic infections through promotion of B cell class switching to IgE. 
Th17 cells produce IL-17A, IL-17F, IL-21 and IL-22 and play a role in mucosal 
immunity to bacteria and fungi through recruitment of neutrophils but have also 
been implicated in various autoimmune diseases.  CD4+ T cells can also 
differentiate into Treg cells with immunosuppressive function. These cells can 
either arise directly in the thymus (tTreg), or from naïve T cells in the periphery 
(pTreg). Treg cells differentiated in vitro are also referred to as inducible Treg  
(iTreg) cells. Treg cells are distinguished by the production of transforming 
growth factor-β (TGF-β) which suppresses unwanted immune responses to 
commensals, self-antigen and innocuous environmental antigens encountered 
at barrier sites. In addition to these well-characterized  CD4+ T-cell subsets, 
new lineages are emerging, defined by novel cytokine profiles and distinct 
transcriptional regulators, for example Th9 and the enigmatic follicular T helper 
(Tfh) cell subset (Hatzi et al., 2015; Veldhoen et al., 2008). These subsets are 
considered distinct lineages based on the selective expression of ‘master 
regulator’ transcription factors, which are necessary and sufficient for lineage 
specification.  T-bet is selectively expressed in Th1 cells, Th17 cells express 
RORγt, Th2 cells express GATA3, and Treg cells are defined by Foxp3 
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expression (Fontenot et al., 2003; Ivanov et al., 2006; Szabo et al., 2000; Zheng 
and Flavell, 1997).   
 
The concept of a ‘master regulator’ implies that a single transcription 
factor can impart the phenotype of its respective lineage. However, this 
oversimplifies the transcriptional landscape of T helper cells. Chromatin 
immunoprecipitation coupled with genome wide sequencing (ChIP-seq) has 
identified networks of transcription factors which dictate T cell phenotype 
(Ciofani et al., 2012). These transcription factors are deployed in a tightly 
controlled spatiotemporal manner to direct gene expression programs specific 
for CD4+ T cell subsets in response to extracellular cues. 
 
Environmental signals direct T helper cell fate 
Extracellular cues are key determinants of naïve CD4+ cell fate. Cytokines 
signal through the janus kinase–signal transducer and activator of transcription 
(Jak-STAT) signaling pathway. Naïve CD4+ T cells constitutively express basal 
levels of STAT proteins. Signaling through cytokine receptors leads to 
phosphorylation of the relevant STAT family member in the cytosol resulting in 
dimerization and translocation to the nucleus to bind to target cis-regulatory 
elements and initiation of lineage specific gene expression (O'Shea et al., 
2011). Thus, STATs operate as signal dependent transcription factors, 
converting extracellular events to induction of genes which drive transcription 
factors.   
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Central to the role of STATs in lineage specification is the induction of 
the relevant ‘master regulator’ transcription factor. In Th1 cells, early expression 
of T-bet following TCR activation is dependent on IFN-γ induced STAT1 
activation, whereas late expression of T-bet, post termination of TCR signaling, 
has been shown to be dependent on IL-12/STAT4 (Schulz et al., 2009). Th2 
differentiation is instructed by IL-4 activation of STAT6 which in turn drives 
expression of GATA3 (Kaplan et al., 1996). Induction of the Th17 pathway is 
more complex as the Th17 lineage shows considerably heterogeneity, in part 
due to the number of cytokine conditions involving combinations of IL-6, TGF-
β1, IL-1 and IL-23 that can drive Th17 differentiation in vitro (Basu et al., 2013; 
Veldhoen et al., 2006). IL-6 appears to be critical for Th17 specification and is 
the principal activator of STAT3 in the early phase of Th17 differentiation. Th17 
cells produce IL-21 which serves to maintain STAT3 signaling, providing 
autocrine regulation of the Th17 phenotype. IL-1 promotes the NF-κB 
transcription factor IRAK (IL-1 receptor-activated kinase) which enhances 
phosphorylation of STAT3 (Mills et al., 2013). More recently it was shown that 
IL-1 can amplify STAT3 signaling through inhibition of SOCS3, a negative 
regulator of STAT3 signaling (Basu et al., 2015). In the same study, IL-1 was 
shown to be critical for Th17 responses in vivo, resolving a long-standing 
controversy over the requirement for IL-1 in Th17 differentiation. Th17 
development is closely intertwined with iTreg differentiation; these two cell-types 
share a requirement for TGF-β (Bettelli et al., 2006). In the absence of IL-6, 
TGF-β together with IL-2 drives the conversion of naïve T-cells to Foxp3+ Tregs 
(Chen et al., 2003; Mucida et al., 2007; Xiao et al., 2008). IL-2 activates STAT5 
which binds to the Foxp3 promoter and this pathway is critical for iTreg 
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differentiation (Davidson et al., 2007) IL-2/STAT5 signaling also enhances Th1 
and Th2 differentiation (Liao et al., 2011). 
 
Lineage stability vs. plasticity 
Despite being classified as lineages, the presence of hybrid CD4+ T cells which 
co-express cytokines and transcription factors from different subsets suggests 
that a considerable degree of plasticity exists between CD4+ T cell lineages 
(O'Shea, 2010). Early during differentiation, Th17 cells exhibit transient flexibility 
with co-expression of Foxp3 and RORγt, and at later stages of development 
Th17 cells can be readily converted to “Th1 like” cells expressing T-bet and 
IFN-γ, as well as Tfh and regulatory IL-10+ (Tr1) cells (Gagliani et al., 2015; 
Garefalaki et al., 2011; Hirota et al., 2013; Lee et al., 2009). Conversely, 
transdifferentiation of Treg cells to Th17 cells has also been demonstrated in 
response to inflammation (Komatsu et al., 2014). Recent studies have identifed 
Treg populations that co-express lineage-specific transcription factors from 
effector T cell subsets, including T-bet, GATA3 or Bcl6 (Chaudhry et al., 2009; 
Chung et al., 2011; Koch et al., 2009; Zheng et al., 2009). These hybrid 
phenotypes provide functional advantages, enabling Tregs to control subset 
specific responses. For example T-bet expressing Treg cells express the 
chemokine receptor CXCR3 and can home to sites of Th1 mediated 
inflammation (Koch et al., 2009). Th1 and Th2 cells were traditionally 
considered more stable relative to their Th17 and Treg counterparts. This was 
challenged by a recent study demonstrating reprogramming of in vitro 
generated Th2 cells toward a Th1 phenotype in response to viral infection in 
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vivo (Hegazy et al., 2010). To date, no studies have identified plasticity of Th1 
cells.  
 
Although developmental flexibility between CD4+ T cell subsets is 
functionally advantageous, providing breadth to the immune response and 
sensitivity to changes in the extracellular environment, dysregulated CD4+ T cell 
responses underlie a number of immune mediated diseases including allergic 
and autoimmune disease. IFN-γ+ Th17 cells have been implicated in several 
human autoimmune diseases including inflammatory bowel disease 
(Annunziato et al., 2007), juvenile idiopathic arthritis (Nistala et al., 2010), and 
multiple sclerosis (Kebir et al., 2009); ex-Foxp3+ Th17 cells play a pathogenic 
role in rheumatoid arthritis (Komatsu et al., 2014); and IL-17+ Th2 cells have 
been positively linked to the severity of asthma (Irvin et al., 2014). Elucidation of 
the developmental pathways for these hybrid cells and identification of the 
factors that regulate CD4+ T cell plasticity will allow the development of 
therapeutic strategies to restore imbalances between T helper cell subsets 
observed in disease states.  
 
Counter regulatory transcriptional networks maintain T-cell commitment 
Maintenance of T-cell lineage commitment requires suppression of factors 
which instruct alternative cell fates. Lineage defining ‘master regulators’ and 
STATs not only enforce a particular lineage but also serve to antagonize 
alternative cell fates. For instance, STAT5 and STAT3 reciprocally regulate 
iTreg and Th17 differentiation (Basu et al., 2015; Laurence et al., 2007). Their 
reciprocal action is achieved in part through competitive antagonism of DNA 
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binding. T-bet directly binds to GATA3 and these transcription factors share a 
set of binding targets, suggesting competitive regulation of gene expression 
(Kanhere et al., 2012). T-bet also inhibits Th17 differentiation by competitively 
inhibiting Runx1 binding and activation of Rorc (Lazarevic et al., 2011).  RORγt 
and Foxp3 exhibit extensive overlap in their DNA targets suggesting reciprocal 
regulation of Th17 and iTreg programs (Xiao et al.,2014). Thus, maintenance of 
a particular T helper cell phenotype requires both stable expression of lineage 
defining transcription factors and active repression of responsiveness to 
cytokines that can instruct opposing factors.  
 
Epigenetic regulation of T helper cell lineage specification  
Instruction of divergent cell fates by lineage defining transcription factors 
requires the induction of distinct transcriptional networks resulting in temporal 
changes in gene expression. In order for transcription factors to mediate 
changes in gene expression, they must first bind to their cognate DNA binding 
motif at cis-regulatory elements in the genome. Epigenetic alterations in the 
chromatin landscape are critical in determining accessibility of DNA to 
transcription factor binding. A number of chromatin modifications have been 
identified that delineate ‘active’ accessible and ‘repressive’ inaccessible 
chromatin. Recent technological advances in the study of genome wide 
epigenetic modifications have highlighted the cell specific nature of epigenetic 
modifications that accompany transitions in cell fate (Hawkins et al., 2013; 
Vahedi et al., 2015; Wei et al., 2102). Thus, cellular differentiation requires 
coordinated changes in transcription factor expression and recruitment of 
epigenetic regulators to chromatin.  
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Chromatin modifications can broadly be divided into two categories: 
covalent modifications to histone proteins such as acetylation, phosphorylation 
and methylation; and DNA methylation (Calo and Wysocka, 2013; Ziller et al., 
2013). These chromatin modifications are mediated by an array of coactivator 
and corepressor proteins possessing enzymatic activity.  These proteins do not 
possess DNA binding activity and their site of action must be determined by 
transcription factors that are able to bind cis elements in the DNA and at the 
same time recruit epigenetic modifiers through protein-protein interactions. 
 
Selection of cell type specific enhancers 
Distal cis-regulatory regions termed enhancers are genetic elements that have 
the potential to enhance transcription levels from gene promoters, often located 
hundreds to kilo-base pairs from the enhancer element.  Enhancers function as 
binding platforms for clusters of lineage-determining transcription factors and 
signal-dependent transcription factors which drive enhancer activation, inducing 
looping of the enhancer to its target promoter and delivery of enhancer 
associated factors (Calo and Wysocka, 2013). Genome wide mapping of 
enhancer elements has revealed cell-type specific patterns of active enhancer 
elements with dynamic changes in the complement of enhancers during cell 
differentiation (Lara-Astiaso et al., 2014; Hawkins et al., 2013). Binding of 
transcription factors in response to cell signaling events occurs primarily at 
enhancers that are already poised for activation (Heintzman et al., 2009; 2007), 
leading to the idea that cell type specific gene expression is determined by the 
enhancer landscape.  
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In order to establish an active enhancer a number of steps must occur. A 
widely accepted model is that “pioneer” factors with the ability to bind 
nucleosomal DNA bind to primed enhancer elements marked by H3K4me1, and 
facilitate binding of other transcription factors by nucleosomal depletion and 
recruitment of chromatin modifiers to generate accessible, ‘permissive’ 
enhancers (Rothenberg et al., 2013). Binding of the relevant transcription 
factors to accessible regions leads to recruitment of coactivators such as the 
histone-aetyltransferases (HATs) p300 and CBP (Chan and La Thangue, 2001). 
This is followed by recruitment of RNA polymerase II (Pol II) and transcription 
from the enhancer region to generate enhancer RNAs (De Santa et al., 2010; 
Kim et al., 2010). eRNAs are critical for enhancer functionality and allow looping 
of the enhancer to the promoter through an as yet unidentified mechanism. 
Acetylation of H3K27 (H3K27ac) by HATs not only increases the accessibility of 
enhancer regions, but plays a role in transcription as H3K27ac was recently 
shown to regulate the activity of RNA Pol II (Stasevich et al., 2014). 
 
Advances in next-generation high-throughput DNA sequencing have 
enabled mapping of the epigenetic landscape. Using a combination of histone 
modifications (H3K4me1 and H3K27ac) as well as p300 binding it is possible to 
identify enhancer elements on a genome wide scale (Heintzman et al., 2009; 
Rada-Iglesias et al., 2010). Elements marked by monomethylation of histone 
H3 lysine 4 (H3K4me1) in the absence of histone acetylation are considered to 
indicate ‘permissive’ enhancers. The presence of p300 together with H3K27ac 
indicates an active enhancer (Rada-Iglesias et al., 2010) where the presence of 
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H3K27ac correlates with enhancer activation and levels of eRNA transcripts 
(Creyghton et al., 2010).  In embryonic stem cells (ESCs), p300 may be bound 
in the absence of H3K27ac but together with the repressive mark, H3K27me3 
(Rada-Iglesias et al., 2010). These enhancers are considered to be ‘poised’ for 
activation. 
 
Super-enhancers regulate cell identity 
The distribution of cell-specific enhancers is asymmetric with some genes 
located in regions with multiple enhancers. Although there are thousands of 
putative enhancers in any given cell type, there are only a few hundred regions 
marked by clusters of enhancers, spanning several thousand base pairs, so 
called ‘super-enhancer’ (SE) regions (Whyte et al., 2013). Whilst typical 
enhancers govern the majority of genes expressed by a particular cell type, 
genes with high levels of cell type specific expression are enriched for super-
enhancers suggesting that these regions are important for cell identity. The 
importance of super-enhancers is demonstrated by the finding that cell-specific 
super-enhancers are enriched for SNPs associated with diseases relevant to 
that cell type (Vahedi et al., 2015). A recent study of super-enhancers in CD4+ T 
cell subsets identified enrichment of super-enhancers at cytokine loci and 
transcriptional regulators (Vahedi et al., 2015). These findings suggest that 
disruption of transcription factor binding at enhancers can have a profound 





Enhancer activation in T helper cells 
Given the importance of enhancers in cell specific gene expression, the 
mechanisms that underlie lineage specific enhancer activation during T cell 
differentiation have been an area of intense investigation. TCR signaling 
induced transcription factors, such as NFAT and activating protein-1 (AP-1), are 
thought to act as pioneer factors although it is not clear how these common 
signals select lineage specific enhancers.  The best-characterised pioneer 
factors are BATF and IRF4 which co-operatively bind cis-regulatory elements in 
non-polarised, activated CD4+ T cells and facilitate binding of the core Th17 
transcription factors: RORγt and STAT3 (Ciofani et al., 2012). The expression of 
BATF and IRF4 is upregulated following TCR stimulation, independent of the 
cytokine milieu, suggesting a potential pioneering role for these transcription 
factors in other T helper cell lineages. However BATF–/– mice have no overt 
impairment in Th1 responses, arguing against this model (Schraml et al., 2009). 
Temporal studies of transcription factor binding are required to dissect out the 
hierarchy of transcription factor binding at primed enhancers in the remaining T 
helper cell subsets.  
 
The pioneer factors may be elusive, but recent studies have shed light 
on downstream events required for enhancer activation.  Lineage-specific 
enhancers are enriched for the relevant lineage-determining transcription 
motifs, pointing towards a potential role for these factors in enhancer activation. 
Surprisingly, the master regulators, T-bet, GATA3 and RORγt, were found to 
have only a minor role in regulating the enhancer landscape (Vahedi et al., 
2012; Xiao et al. 2014). Instead, studies in Th1 and Th2 cells suggest that 
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STAT proteins play a global role in enhancer activation, as cells deficient in the 
relevant STAT protein exhibited loss of p300 at enhancers (Vahedi et al., 2012). 
In Th2 cells, H3K4me1 deposition was also affected by loss of STAT6 and in a 
separate study, STAT6 occupancy at enhancers was found to precede 
enhancer activation during Th2 differentiation (Hawkins et al., 2013). STAT6 
may therefore be a pioneer factor in Th2 cells.  It is unclear to what extent STAT 
proteins can directly recruit p300 or whether they co-operate with other factors 
with the ability to modify chromatin.  
 
An epigenetic basis for T helper cell plasticity 
Epigenetic modifications not only permit transcription factor binding and 
downstream transcriptional activation but can also inhibit transcription factor 
activity. Repressive marks associated with closed chromatin structure prevent 
access of TFs to their target genes. Thus, epigenetic modifications can 
reinforce cell fate decisions and raise barriers that must be overcome for cells to 
adopt alternative phenotypes in response to extracellular cues. This was 
highlighted by genome-wide mapping of active and repressive marks H3K4me3 
and H3K27me3 respectively, in CD4+ T cell subsets (Wei et al., 2102).  Gene 
loci for the relevant lineage-specific TFs and cytokines are marked by H3K4me3 
while repressive marks are present at genes associated with alternative T-
helper cell subsets. Bivalent domains marked by both H3K4me3 and 
H3K27me3 are considered to be ‘poised’ for activation or repression. An 
epigenetic basis for plasticity observed in Th17 cells and iTregs is suggested by 
the presence of bivalent markers at transcription factor and cytokine loci 
associated with alternative cell fates (Wei et al., 2102). One caveat to the 
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interpretation of these studies is the use of bulk cell populations for ChIP-seq. It 
is possible that bivalent domains represent two populations of cells with either 
H3K4me3 or H3K27me3 at a particular locus rather than the co-existence of 
these marks within a single cell. Single-cell epigenomic profiling is required to 
address this question.  
 
A further example of an epigenetic basis for CD4+ T cell plasticity is 
observed in Treg cells. iTreg and tTreg both express Foxp3. However, iTregs 
exhibit phenotypic instability, readily adopting gene expression profiles 
associated with effector T cell subsets. Examination of the epigenetic landscape 
at the Foxp3 locus reveals distinct chromatin modifications. The Foxp3 locus 
remains methylated in iTregs, similar to naïve CD4+ T-cells, whereas tTregs can 
be distinguished by a demethylated Foxp3 locus (Huehn et al., 2009). These 
studies have enhanced our understanding of T helper cell differentiation and 
have spurned a wealth of interest in the epigenetic mechanisms that regulate T 
helper cell fate. 
 
Enhancers maintain lineage stability 
Epigenetic modifications are preserved through rounds of cell division and may 
explain the stability of gene expression changes induced by signal-dependent 
transcription factors, long after the initiating extrinsic cues are removed from the 
environment. Temporal examination of enhancer states during human Th1 and 
Th2 differentiation showed that enhancers remain active during late phase of 
differentiation, suggesting that enhancers are required for stable gene 
expression and maintenance of cell fate commitment (Hawkins et al., 2013).  At 
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present, it is not clear whether enhancers are required to initiate transcription 
and/or sustain gene expression. Given that cellular plasticity requires the 
remodeling of enhancer regions in response to extracellular cues, it has been 
proposed that epigenetic regulators play a critical role in regulating lineage 
plasticity or stability. 
 
Nuclear hormone signal dependent transcription factors  
What is clear from the study of enhancer activation in cells outside of the 
immune system is that multiple signals are required for enhancers to become 
fully functional. As well as recruitment of p300, a number of coactivator 
complexes are required for enhancer functionality. No single transcription factor 
can drive enhancer activation, rather a complex of transcription factors 
collaboratively bind in a temporal order through DNA and protein-protein 
interactions. The ability of STAT proteins to shape the enhancer landscape 
points to a potential role for other signal dependent transcription factors in 
translating changes in the microenvironment to chromatin. Potential candidates 
include nuclear hormone receptors which are activated by a diverse group of 
ligands including hormones, vitamins and lipids. Of particular interest are the 
retinoic acid receptors.  This is because retinoic acid (RA), the active metabolite 
of vitamin A, is actively synthesized at sites of T cell priming and has been 





Vitamin A: an essential nutrient for immunological health 
 
Vitamin A, through its active derivative retinoic acid (RA), plays a critical role in 
embryogenesis, determining cell lineage and fate commitment (Niederreither 
and Dollé, 2008). In areas where malnutrition is endemic, vitamin A deficient 
(VAD) children have an increased burden of infectious disease (Sommer et al., 
1986), highlighting the importance of vitamin A for immunity. The pivotal 
discovery that RA was constitutively synthesized by gut dendritic cells (DCs) 
was closely followed by several studies showing that RA was able to enhance 
induction of iTreg cells.  These findings led to the view that RA might act to 
promote oral tolerance and shifted the attention away from the critical nature of 
RA in peripheral, effector immune responses. In recent years a broader role for 
RA in systemic immunity has re-emerged. Several studies have demonstrated 
regional induction of RA synthesis and signaling upon inflammation (Guo et al., 
2012; Pino-Lagos et al., 2011), and RA has been shown to play an essential 
role in Th1 responses in allograft rejection, vaccination and gut infection (Hall et 
al., 2011; Pino-Lagos et al., 2011). These recent advances have shed light on a 
broader role for RA in directing T-helper cell fate, outside of the mucosal 
immune system.  
 
Retinoic acid is synthesized at sites of inflammation 
Multiple isoforms of RA exist. Of these, all-trans retinoic acid (ATRA) is the 
predominant biological form. RA is generated from retinol, which circulates in 
the plasma bound to retinol binding protein. RA synthesis is restricted to cells 
that express the enzymes required for conversion of retinol to RA. First, retinol 
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is converted to retinal by retinol dehydrogenase (RDH). Studies in rdh10–/– mice 
suggest that RDH10 is the critical isoform for retinal synthesis (Napoli, 2012). 
Retinal is then irreversibly converted to RA by one of three retinaldehyde 
dehydrogenase isoforms: RALDH1, RALDH2 or RALDH3 encoded by aldh1a1, 
aldh1a2, and aldh1a3, respectively (Lin et al., 2003; Niederreither et al., 1999).  
A role for RA in mucosal immunity was established by the discovery that 
dendritic cells within the mesenteric lymph node (MLN) and Peyer’s patches 
(PP) constitutively express aldh1a2 and aldh1a1 respectively, and that RA 
could imprint gut tropism on T-cells through the induction of gut-homing 
receptors, CCR9 and α4β7 (Iwata et al., 2004). Within both human and murine 
MLNs, DCs that express the highest levels of aldh1a2 are the CD103+ subset 
(Coombes et al., 2007; Jaensson et al., 2008). Recently, it was shown that 
expression of 4-1BB, a member of the TNF receptor superfamily, correlates with 
CD103 positivity in dendritic cells and 4-1BB is therefore also able to identify 
MLN DCs with the highest levels of aldh1a2 (Lee et al., 2012). Triggering of 4-
1BB induced RALDH activity in vitro and 4-1BB deficient MLN DCs have weak 
RALDH activity pointing to a functional role for 4-1BB in the induction of RA 
synthesis.  
 
Outside of the gut, examination of peripheral DC subsets have identified 
DCs expressing aldh1a2 residing in the lung and skin, pointing to a role for RA 
in steady state immune responses at barrier sites (Guilliams et al., 2010; 
Gyöngyösi et al., 2013). Although the majority of peripheral DCs express 
negligible or low levels of RALDH, the identification of cytokines and pathogen-
associated molecular patterns that can induce RALDH expression indicates that 
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RA synthesis and signaling may be a widespread occurrence during the course 
of a peripheral immune response. Treatment of splenic DCs with zymosan, a 
TLR-2 agonist, results in the induction of aldh1a2 in vitro, and stimulation of WT 
but not TLR2–/– splenic DCs with Candida albicans has a similar effect 
(Manicassamy and Pulendran, 2009). In vitro, GM-CSF can induce both bone 
marrow-derived DCs and splenic DCs to express aldh1a2 (Yokota et al., 2009).  
 
Several in vivo studies have now demonstrated local induction of RALDH 
activity amongst DCs in response to a diverse array of inflammatory stimuli 
including viral infection, alloantigen and tumour burden (Guo et al., 2012; Wang 
et al., 2014),(Allie et al., 2013; Mielke et al., 2013; Pino-Lagos et al., 2011). In 
addition to RA synthesis by DCs, upregulation of aldh1a2 expression has been 
observed in alternatively activated macrophages following infection with the 
helminth Shistosoma mansoni (Broadhurst et al., 2012). These studies suggest 
that RA synthesis and signaling may be a universal feature of immune 
responses both in the gut and the periphery. Intriguingly, peripheral induction of 
T and B cell responses in the presence of RA still leads to induction of gut 
homing receptors (Hammerschmidt et al., 2011; Wang et al., 2014). Induction of 
CCR9 expression on lung derived CD4+ T-cells following intranasal influenza 
infection resulted in trafficking of these cells to the small intestine. Local 
production of IFN-γ resulted in alterations to the gut microbiota which in turn led 
to increased numbers of intestinal Th17 cells. These findings explain the 
incidence of intestinal side effects observed in influenza patients but the 
functional relevance of gut homing to the primary immune response remains to 
be determined. Recent discoveries have shown that systemic immune 
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responses at sites distal to the gut are modulated through the gut microbiota 
(Lee et al., 2011; Wu et al., 2010) and it is possible that lymphocyte trafficking 
through the gut is a necessary rite of passage for effector T-cells. Regional RA 
production at peripheral sites of inflammation with subsequent induction of gut 
homing properties on lymphocytes may play a key role in shaping the course of 
the immune response. Regardless of the significance of RA in directing gut 
homing, the overall message from these studies is that RA synthesis and 
signaling at sites outside of the mucosal tissue, points to a global role for RA in 
the regulation of CD4+ T-cell mediated immune responses. 
 
RA regulation of T helper cell fate and plasticity  
 
RA enhances iTreg differentiation and Treg stability 
Following the initial study that identified RA synthesis by gut DCs, several 
groups went on to show that RA could dramatically enhance the TCR-TGF-β-
mediated conversion of naïve CD4+ T cells to iTreg in vitro (Benson et al., 2007; 
Coombes et al., 2007; Mucida et al., 2007). TGF-β mediated Foxp3 induction is 
dependent on Smad3 (Tone et al., 2008; Zheng et al., 2010). In addition to 
directly regulating the expression of Smad3 (Xiao et al., 2008), RA regulation of 
Foxp3 expression is in part mediated by binding of RAR/RXR heterodimers to a 
RA response element (RARE) in the enhancer 1 (CNS1) region of the Foxp3 
gene, which facilitates binding of phosphorylated Smad3 to the enhancer region 
(Xu et al., 2010). The first in vivo evidence supporting a role for the RA/TGF-β-
Smad3 pathway in the generation of pTreg cells in the GALT comes from a 
recent study utilizing mice lacking the Smad3 binding site within the CNS1 
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region. Aged mice develop deficiencies in Foxp3+ cells in the LP and PP; 
however, the functional significance of this is unclear since no negative impact 
of the pTreg deficiency was observed in T-independent or T-cell-dependent 
models of colitis (Schlenner et al., 2012). Further studies are required to 
understand the in vivo contribution of RA to immune tolerance, both in the gut 
as well as at peripheral sites of immune responses.  
 
In addition to enhancing TCR-TGF-β mediated Foxp3 expression, RA 
has also been shown to confer increased stability of Foxp3 expression in the 
face of inflammatory cytokines and co-stimulation amongst both iTreg and tTreg 
cells (Benson et al., 2007; Xiao et al., 2008) (Zhou et al., 2010).  iTregs 
generated in the presence of RA express reduced levels of the receptor for IL-6, 
a Th17 instructing cytokine (Hill et al., 2008). Recently, RA and TGF-β were 
shown to induce expression of the microRNA miR-10a, which in turn inhibited 
expression of the Tfh master transcription factor, Bcl-6 (Takahashi et al., 2012). 
Conversion of Treg to Tfh cells has been described in PP (Tsuji et al., 2009), 
and miR10-a overexpression in iTreg cells was able to reduce this conversion in 
vivo (Takahashi et al., 2012). RA may therefore reinforce lineage stability by 
regulating opposing pathways that instruct alternative T helper cell fates. 
 
A newly described role for RA in the conversion of CD4+ T-cells to 
CD4+CD8αα+ T cells within the intestinal epithelium provides a further 
mechanism by which RA promotes anti-inflammatory responses within the gut 
(Reis et al., 2013). Cd4creRosa26dnRara/dnRara mice conditionally expressing a 
dominant negative form of the retinoic acid receptor RARα in CD4+ T-cells 
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(henceforth referred to as dnRara mice) have severely impaired numbers of 
CD4+CD8α+ IELs, which appear to play a critical role in preventing intestinal 
inflammation. dnRara CD4+ T cells fail to upregulate T-bet, which is required for 
induction of Runx3. Runx3 inhibits ThPok allowing reprogramming of CD4+ cells 
towards CD8α+ IELs. The ability of RA to regulate expression of T-bet, the key 
Th1 transcription factor, hints at a broader role for RA in the regulation of T 
helper cell responses. 
 
Retinoic acid is critical for CD4+ effector Th1 responses in vivo 
A role for RA in the generation of Treg cells seemed counterintuitive given the 
wealth of epidemiological data supporting a role for RA in immunity to infectious 
disease. Emerging data, which examines the effects of RA on effector 
lymphocytes in vivo, have gone someway to resolving this paradox by 
demonstrating a broader role for RA in T helper cell responses. Our own studies 
using dnRara mice demonstrate a critical role for RA in the development of Th1 
mediated immunity in a model of allograft rejection (Hall et al., 2011; Pino-
Lagos et al., 2011). In keeping with the ability of RA to regulate Th1 
differentiation, VAD mice infected with Toxoplasma gondii were found to have 
significantly reduced Th1 cells in their GALT and spleen (Hall et al., 2011). In 
the same study, VAD mice were also shown to have deficient Th1 cell 
responses in response to vaccination with ovalbumin (OVA) and E. coli toxin.   
 
The molecular mechanism through which RA controls Th1 cell fate 
remains unclear. In vitro experiments conducted with CD4+ T cells isolated from 
RARα–/– mice suggest that disruption of RA signaling leads to impaired 
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activation induced proliferation (Hall et al., 2011). However, dnRara expressing 
CD4+ T cells have normal proliferative capacity (Pino-Lagos et al., 2011). One 
possible explanation for this discrepancy is that unliganded RARs inhibit 
transcription through recruitment of corepressors (Kurokawa et al., 1995). In this 
case, deletion of RARα could lead to a loss of inhibition of RAR targets, and a 
paradoxical up-regulation of RA target genes in the absence of RA.  In 
zebrafish, deletion of RAR isoforms resulted in a paradoxical increase in RA 
signaling with compensatory increases in expression of alternative RARs 
(D'Aniello et al., 2013).  RARα does appear to be the critical receptor in 
mediating the effects of RA on CD4+ T-cells as deletion of RARγ in 
haematopoietic cells had no impact on the development of Th1 responses 
following infection with Listeria monocytogenes (Dzhagalov and Chambon, 
2007). To date, no studies have examined transcriptional targets of RARα 
on a genome wide scale in Th1 cells and the precise mechanisms 
underlying RA/RARα regulation of Th1 differentiation remain undefined. 
Work described in Chapter 2 will address this question. 
 
In contrast to a physiological role for RA in supporting Th1 differentiation, 
RA treatment of naive CD4+ T-cells polarised under Th1 conditions in vitro 
inhibits IFN-γ production (Iwata et al., 2003).  It is unclear whether this reflects 
suppression of the full Th1 program through inhibition of T-bet or a limited effect 
of RA on cytokine production and/or secretion. RA has been shown to inhibit 
cytokine production by memory T cells in a non-lineage-specific manner. RA 
may therefore play distinct temporal roles during T cell differentiation, 
enhancing or limiting effector function.  
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Retinoic acid shapes Th17 responses 
In addition to shaping Th1 responses, RA has also been shown to regulate 
Th17 differentiation. The earliest studies linking RA to TGF-β mediated Foxp3+ 
expression identified a reciprocal role for RA in the inhibition of Th17 cells 
differentiated from naïve CD4+ T cells with TGF-β and IL-6 in vitro. This appears 
to be in part due to reduced expression of IL-6R and IL-23R in responder T-
cells (Xiao et al., 2008). Interestingly, the inhibitory effects of RA on Th17 
differentiation are most prominent in the presence of IL-2 (Takahashi et al., 
2012). IL-2 activation of STAT5 antagonises STAT3 and RA inhibition of Th17 
differentiation is dependent on STAT5 (Takahashi et al., 2012; Xiao et al., 
2008). Consistent with these in vitro findings, RA administration in vivo inhibits 
the development of Th17 responses and disease severity in experimental 
autoimmune encephalitis (EAE), a Th17 mediated autoimmune disease (Xiao et 
al., 2008). While pharmacological doses of RA inhibit Th17 generation, 
physiological levels of RA (<10nm), have been shown to enhance Th17 
generation in vitro (Takahashi et al., 2012). In support of an in vivo role for RA 
in the generation or maintenance of Th17 cells, studies in VAD mice describe a 
near absence of Th17 cells both during homeostasis and in response to 
immune-mediated inflammation (Hall et al., 2011; Wang et al., 2010). However, 
two recent studies have identified a role for RA in the generation of type 3 
innate lymphoid cells (ILC3s), which mirror Th17 cells in their cytokine profile. 
VAD mice and mice treated with an RA antagonist had impaired ILC3 
responses both in steady state and in response to intestinal infection with 
Citrobacter rodentium (Spencer et al., 2014). ILC3s produce Th17 associated 
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cytokines and their absence in VAD mice may contribute to the impaired 
development of Th17 cells at the mucosal surface.  Further studies are required 
in dnRara mice to establish the cell intrinsic role of RA/RARα in Th17 
generation. Studies in Chapter 3 will start to address a role for RARα in 
Th17 differentiation.   
 
The absence of ILC3s in VAD mice has widespread implications for 
adaptive immune responses since a subset of ILC3s - lymphoid tissue inducer 
(LTi) cells - play a critical role in the development of secondary lymphoid organs 
and Peyer’s patches. Maternal vitamin A and fetal RA signaling were found to 
directly regulate the expression of RORγt, instructing the development of LTis 
(van de Pavert et al., 2014).  Mice exposed to an RA-deficient environment in 
utero had smaller secondary lymphoid organs which persisted in adult life 
resulting in impaired adaptive immune responses. Since many earlier studies 
have used VAD as a model for studying RA regulated dynamic T-cell 
responses, these studies must be re-evaluated in light of the widespread 
homeostatic defects observed in these mice. 
 
Role of retinoic acid in Th2 differentiation 
In addition to Th1 and Th17 mediated immune responses, RA synthesis has 
been reported in parasite infections suggesting a possible role for RA in 
shaping Th2 responses. Dietary VA levels have been shown to affect Th2 
responses. For instance, enhanced production of Th2-associated cytokines, 
and concomitant reduction in IFN-γ, are observed in CD4+ T cells isolated from 
Trichinella spiralis infected VAD mice (Cantorna et al., 1994). However, a 
! 38!
further twist is provided by the earlier study examining ILC dysregulation. In 
this, VAD induced expansion of ILC2s, leading to enhanced ILC2 derived Th2 
type cytokines (Spencer et al., 2014). The presence of ILC2s appears to be 
critical for Th2 allergen responses in vivo (Halim et al., 2014). Thus, previously 
reported effects of dietary RA on Th2-cell responses in VAD mice may not be 
due to direct effects of RA on T cells.  Studies in which RA levels are 
manipulated through administration of RA are conflicting with both enhanced 
and reduced Th2 responses reported in murine models of asthma following RA 
treatment (Schuster et al., 2008; Wu et al., 2013).  
 
The preponderance of data from in vitro experiments, in which dose 
titration comparisons were performed on Th1, Th2 and Th17 polarisation, 
suggests dose dependent effects of RA on haematopoietic cell fate (Iwata et al., 
2003; Takahashi et al., 2012; Uematsu et al., 2008). The seemingly 
paradoxical, opposite effects of RA on T cell fates may therefore be simply 
explained as concentration-dependence. This would allow T cells to act as an 
environmental sensor, with RA concentration being the signal. Further studies 
of RA gradients within lymphoid tissue are required to test this hypothesis. 
However, the overriding message is that administration of RA either in vitro or to 
vitamin A replete hosts in vivo may not provide insight into the physiological 
actions of RA on T-cell responses. Genetic approaches allow better 
appreciation of the impact of RA signaling on defined lineages of hematopoietic 
cells and will help to clarify the physiological role of RA in the regulation of T 
helper cell fate.  
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Temporal regulation of cell fate by retinoic acid 
A further layer of complexity surrounds RA regulation of T helper cell fate with 
bi-phasic effects of RA on Th1 and Th2 differentiation reported in vitro (Iwata et 
al., 2003). In Th1 differentiation, induction of T-bet is dependent on IFN-
γ/STAT1 signaling whereas maintenance of T-bet expression is dependent on 
IL12/STAT4 activation (Schulz et al., 2009), suggesting distinct roles for RA in 
the regulation of these signaling pathways. Similarly, a bi-phasic model for Th17 
differentiation is emerging with early commitment dependent on TGF-β and IL-6 
signaling, but maintenance and stability dependent on IL-21 and IL-23 signaling 
(Basu et al., 2013). Temporal regulation of cell fate by RA also hints at a 
possible role for RA in regulation of epigenetic modifications which are activated 
in a spatio-temporal manner during cell differentiation. 
 
Retinoic acid signaling: novel mechanisms of transcriptional regulation  
All-trans RA, the biologically active form of VA, signals through heterodimers of 
the RA receptors (RARs) and retinoid X receptors (RXRs) (Chambon, 1996). 
These receptors belong to the nuclear hormone receptor family.  There are 
three isotypes for both RAR and RXR: α, β and γ. RAR/RXR heterodimers bind 
to RA response elements RAREs in target genes and act as ligand dependent 
transcription factors. RAR/RXRs mediate transcriptional regulation through the 
binding of corepressor or coactivator complexes dependent on the presence of 
ligand. The widely accepted view is that unliganded RAR/RXR heterodimers 
inhibit transcription of their target gene, through recruitment of co-repressors 
such as nuclear receptor corepressor (NCoR) and silencing mediator of retinoic 
acid and thyroid hormone receptor (SMRT). Binding of ligand to RAR leads to 
! 40!
release of corepressors and recruitment of coactivators such as p300 and CBP 
to the AF-2 domain with subsequent transcriptional activation of the target gene 
(Nagy and Schwabe, 2004).  In addition, RA can mediate gene repression 
through recruitment of ligand-dependent corepressors, RIP140 and PRAME, 
which recruit histone deacetylases to RAR/RXR complexes to repress their 
activities (Epping et al., 2005; Perissi et al., 2010). RARs can also modulate 
transcription indirectly, through inhibition of transcription factor complexes, such 
as AP-1, although the underlying mechanisms remains uncertain (Nicholson et 
al., 1990).   
 
In addition to its classical role as a transcriptional regulator, recent 
studies in ESCs have identified RA-RARα as an epigenetic regulator. Retinoids 
have been shown to regulate epigenetic changes including histone 
modifications and DNA methylation through the recruitment of coactivators with 
chromatin modifying properties (Gudas, 2013). p300 and CBP possess histone 
acetyltransferase activity and mediate acetylation of H3K27, a marker of active 
cis-regulatory regions. The emerging data implicating RARα in lineage plasticity 
suggest a potential role for RA/RARα in the regulation of the epigenome. Work 
described in Chapters 2 and 3 will investigate this possibility.  
 
Given that RA is synthesised at sites of T-cell priming, RARα can act as 
a signal dependent transcription factor, responding to changes in the 
extracellular environment that becomes licensed during T cell activation. The 
ability of RARα to regulate epigenetic modifcations suggests RARα as a 
candidate molecule for regulation of enhancer landscape in T helper cells.  
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Intriguingly, TCR-signaling is required to observe RA mediated effects on 
lymphocytes pointing to a potential co-operative relationships between RARα 
and TCR-induced transcription factors, such as NF-kB or AP-1 family members. 
Alternatively, TCR-induced pioneer factors may be required for RARα to bind to 
its relevant target genes.  
 
Summary 
Studies of transcriptional changes and chromatin modifications paint a picture 
of tissue-specific programs orchestrated with astonishing precision. Despite 
intense investigation, the precise mechanisms by which enhancers transition to 
full competency during T cell differentiation remain unclear.  Selective activation 
of new enhancer sites during cell-fate transitions is driven by lineage-specific 
factors, yet it remains unclear how TFs bound at enhancers regulate epigenetic 
changes to achieve fine-tuned alterations in gene expression.  Chapter 2 
examines the molecular basis for RA/RARα mediated regulation of Th1 
differentiation and presents data identifying a role for RARα as a regulator of 
enhancers at key Th1 genes. Chapter 3 then explores a broader role for RARα 
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SUMMARY
CD4+ T cells differentiate into phenotypically distinct
T helper cells upon antigenic stimulation. Regulation
of plasticity between these CD4+ T-cell lineages is
critical for immune homeostasis and prevention of
autoimmune disease. However, the factors that regu-
late lineage stability are largely unknown. Here we
investigate a role for retinoic acid (RA) in the regula-
tion of lineage stability using T helper 1 (Th1) cells,
traditionally considered the most phenotypically
stable Th subset. We found that RA, through its
receptor RARa, sustains stable expression of Th1
lineage specifying genes, as well as repressing
genes that instruct Th17-cell fate. RA signaling is
essential for limiting Th1-cell conversion into Th17
effectors and for preventing pathogenic Th17 re-
sponses in vivo. Our study identifies RA-RARa as a
key component of the regulatory network governing
maintenance and plasticity of Th1-cell fate and
defines an additional pathway for the development
of Th17 cells.
INTRODUCTION
Functional plasticity within cells of the innate and adaptive im-
mune system increases the breadth of response to pathogens
while also limiting responses detrimental to the host. CD4+
T cells diversify into distinct effector subsets upon antigenic
stimulation. Cytokines and other microenvironmental factors
present during T-cell priming direct differentiation via induction
of lineage specifying transcription factors (TFs): T-bet is the
‘‘master’’ regulator for T helper 1 (Th1) cells, RORgt for Th17
cells, and GATA3 directs the Th2 program. In vivo, the presence
of cells that express TFs and cytokines from opposing Th line-
ages indicates flexibility between those subsets. Late-stage
developmental plasticity is potentially perilous: interferon-g
(IFN-g+) Th17 cells have been implicated in several human auto-
immune diseases including inflammatory bowel disease (Annun-
ziato et al., 2007), juvenile idiopathic arthritis (Nistala et al., 2010),
and multiple sclerosis (Kebir et al., 2009); ex-Foxp3+ Th17 cells
play a pathogenic role in rheumatoid arthritis (Komatsu et al.,
2014); and interleukin-17 (IL-17+) Th2 cells have been positively
linked to the severity of asthma (Irvin et al., 2014). Elucidating the
developmental pathways for these hybrid cells and identifying
the factors that regulate Th-cell stability are therefore of critical
importance.
Initial lineage specification is driven by cytokines, which acti-
vate signal transducer and activator and transcription (STAT)
proteins: expression of T-bet is driven by IFN-g-STAT1 and IL-
12-STAT4 (Schulz et al., 2009); RORgt by STAT3 downstream
of IL-6, IL-21, and IL-23 (Zhou et al., 2007). Less is known about
the molecular mechanisms that sustain lineage identity. Epige-
netic modifications stabilize gene expression and as such, are
thought to play a key role in themaintenance of cell-fate commit-
ment. However, the factors that co-ordinate chromatin changes
with evolving TF networks in differentiating Th cells are not fully
defined. One candidate is the vitamin A metabolite, retinoic
acid (RA). RA is known to play a key role in directing the lineage
fate of hematopoietic stem cells (Chanda et al., 2013), dendritic
cells (DCs) (Klebanoff et al., 2013), innate lymphoid cells (ILCs)
(Spencer et al., 2014), andCD4+ T cells (Reis et al., 2013) through
activation of the nuclear RA receptor (RAR). In addition to its
classical role as a transcriptional regulator, recent studies in
embryonic stem cells have identified RA-RAR as an epigenetic
regulator (Kashyap et al., 2013; Urvalek and Gudas, 2014). RA
synthesis is dynamically controlled at sites of T-cell priming dur-
ing inflammation, where RA signaling on T cells has been demon-
strated (Aoyama et al., 2013; Pino-Lagos et al., 2011). These
studies suggest a potential role for RA in Th-cell plasticity.
Indeed, RA is critical for Th1-cell immunity (Hall et al., 2011;
Pino-Lagos et al., 2011) and RA has also been implicated
in Th17-cell differentiation where its impact appears to be
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dose dependent: physiological concentrations of RA enhance
Th17-cell differentiation in vitro (Takahashi et al., 2012), yet
administration of higher concentrations of RA both in vitro and
in vivo negatively regulates Th17-cell responses (Mucida et al.,
2007; Takahashi et al., 2012; Xiao et al., 2008). Although RARa
has been identified as the critical mediator of RA actions in
CD4+ T cells (Hall et al., 2011), to date a comprehensive analysis
of the transcriptional targets of RARa in CD4+ T cells has not
been reported and the mechanism by which RA regulates these
distinct Th-cell fates remains unresolved.
Here we show that RA-RARa is critical for maintenance of the
Th1-cell lineage. Loss of RA signaling in Th1 cells resulted in the
emergence of hybrid Th1-Th17 and Th17 effector cells. Global
analysis of RARa binding and enhancer mapping revealed
that RA-RARa directly regulated enhancer activity at Th1-cell-
lineage-defining genes while repressing genes that regulate
Th17-cell fate. In the absence of RA signaling, infectious
and oral antigen induced inflammation resulted in impaired
Th1-cell responseswith deviation toward a Th17-cell phenotype.
These findings identify RA-RARa as a key regulatory node that
acts to sustain the Th1-cell response while repressing Th17-
cell fate.
RESULTS
RA-RARa Regulates the Balance between Th1 and
Th17 Cells
To directly assess the role of RA in Th-cell differentiation in vivo





Figure 1. RA Controls the Balance between
Th1 and Th17 Effector Cells
(A) Splenic CD4+ T cells from dnRara and WT
littermate control mice. Numbers indicate per-
centage CD62LloCD44hi cells (top left) or CD62Lhi
CD44lo T cells (bottom right) gated on CD4+ cells.
(B) Frequency and total number (C) of
CD62LloCD44hi in the CD4+ T-cell population in WT
and dnRara mice (n = 3 or 4 per group).
(D) Intracellular IFN-g and IL-17A expression
in splenic CD4+CD44hi T cells after stimulation
with phorbol 12-myristate 13-acetate (PMA) and
ionoymycin.
(E) Statistical data from cells as in (D).
(F) Quantitative real-time PCR analysis of Tbx21,
Rorc, andGata3 in splenic CD4+CD62loCD44hi cells
(as in 1A), sorted by flow cytometry.
Data are from two or three independent experi-
ments with similar results. Mean ± SEM, *p < 0.05;
****p < 0.0001
See also Figure S1.
negative form of the RA receptor
RARa (RARa403) targeted to ROSA26
downstream of a loxP-flanked ‘‘stop’’
(lsl) cassette. As shown previously (Pino-
Lagos et al., 2011), interbreeding
with mice expressing Cre recombi-
nase from the Cd4 promoter generates
Cd4crednRaralsl/lsl progeny (dnRara mice)
in which RA signaling is abrogated within the T-cell compart-
ment. In contrast to Rara!/! mice, expression of this dnRARa
disrupts the RA dependent activity of RARa while retaining the
ligand independent effects, allowing the specific analysis of
RA-dependent functions.
To investigate the role of RA in the generation of Th-cell sub-
sets under steady-state conditions, we determined the expres-
sion of cytokines within CD4+ T cells with an activated CD44hi
phenotype. Examination of the peripheral CD4+ T-cell compart-
ment revealed equivalent frequencies and absolute numbers of
CD44hiCD62loCD4+ memory cells in 8-week-old dnRara mice
and in Cre!, wild-type (WT), littermate controls (Figures 1A–
1C). dnRara effector cells displayed reduced production of
IFN-g compared to their WT counterparts with a >5-fold increase
in the frequency of IL-17+ cells (Figures 1D and 1E). Examination
of transcripts for the signature lineage-determining TFs showed
reduced mRNA expression of Tbx21 and significantly higher
expression of Rorc in dnRara effector CD4+ T cells (Figure 1F).
Loss of RA signaling had no impact on Th2 effectors with equiv-
alent levels of Gata3 expression between dnRara and WT mice
(Figure 1F) and similar frequencies of IL-4 producing CD4+
T cells (data not shown).
The frequency and numbers of Foxp3+ T cells in the periphery
and thymus of dnRaramice were similar to control mice (Figures
S1A and S1B), indicating that the increase in Th17 cells was not a
consequence of reciprocal regulation by RA of Foxp3+CD4+
T cells and Th17 cells (Mucida et al., 2007). Therefore it is likely
that under steady-state conditions RA is critical for differentiation
of Th1 cells, while also limiting the differentiation of Th17 cells.
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RA Promotes Th1-Cell Differentiation and Inhibits
Development of Th17 Cells from Th1 Cell Precursors
We considered two alternative explanations of why dnRaramice
exhibit reduced memory effector Th1 cells, in parallel with
enhanced Th17 cells. The first possibility was that RA is required
for the development of Th1 cells while independently suppress-
ing the primary differentiation of Th17 cells. The alternative pos-
sibility was that RA is critical in restraining conversion of Th1 cells
to Th17 cells. In order to resolve these two possibilities, naive
CD4+ T cells were differentiated in the presence of Th1 or Th17
polarizing cytokines. dnRara expressing CD4+ T cells differenti-
ated under Th1 cell conditions showed a markedly reduced
capacity for IFN-g production (Figure 2A). Diminished cytokine
production was not a consequence of impaired proliferative
responses as naive CD4+ T cells differentiated under Th1-cell
conditions showed robust proliferation, equivalent to WT cells
(Figure S2A). In addition, upregulation of the activation markers
CD25 and CD44 indicated that dnRara T cells were not impaired
in their ability to differentiate into effector cells (Figure S2B).
Analysis of TF expression showed that ablating RA signaling re-
sulted in a dramatic reduction in the expression of T-bet in CD4+
T cells differentiated under Th1-cell conditions (Figure 2B). Strik-
ingly, a substantial proportion of dnRara Th1 cells expressed
RORgt and co-expression of T-bet and RORgt was observed
at the single-cell level. Although we did not observe intracellular
IL-17A in cells following brief stimulation with phorbol myristate
(PMA) and ionomycin, analysis of supernatants from Th1 polar-
ized cells, reactivated on day 6 of culture on anti-CD3 and
anti-CD28 coated plates for 24 hr in non-polarizing media,
showed increased expression of IL-17A alongside other Th17-
cell-associated cytokines (IL-21 and IL-22) (Figure 2C). Further-
more, mRNA analysis of dnRara Th1 polarized cells revealed
dramatic increases in expression of key signature Th17-cell
genes (Figure 2D). Notably, these Th1 cells displayed the hall-
marks of pathogenic Th17 cells with high amounts of Il23r
expression but reduced amounts of IL-10 mRNA and protein
(Figures 2C and 2D) (Basu et al., 2013).
In order to assess whether enhanced Th17 responses were a
general feature of CD4+ T cells in which RA signaling is disrupted,
naive CD4+ T cells from dnRara mice were differentiated under
Th17 polarizing conditions. In contrast to our observations
above, we did not observe an increase in the frequency of IL-
17+ cells in dnRara mice during primary differentiation into
Th17 cells (Figure S2C), suggesting that RA restrains Th17-cell
differentiation only in the context of a Th1 polarizing cytokine
milieu. In support of this, RORgt expression was not observed
in dnRara expressing naive CD4+ T cells differentiated under
Th0 or Th2 conditions (Figure S2D).
The simultaneous expression of RORgt and T-bet in dnRara
Th1 cells suggested that RA-RARa might act to constrain the
deviation of Th1 committed cells toward the Th17-cell lineage.
To determine whether the RORgt+ cells represented a distinct
T-cell population that arose directly from naive CD4+ T cells or
from previously committed Th1 cells, we interbred IfngeYFP
(Great) reporter mice with the dnRara mice to allow the tracking
of IFN-g+ cells. Naive CD4+ T cells from dnRara-IfngeYFP or litter-
mate control mice were activated under Th1 polarizing condi-
tions. On day 7 of culture, eYFP+ (IFN-g+) cells were FACS sorted
and underwent genome-wide expression analysis. Key signature
Th17-cell genes, including Th17-cell cytokines and receptors for
cytokines that promote Th17-cell differentiation (Il17f, Il21, Il1r1,
Il6ra, and Il23r), were highly expressed in dnRara IFN-g express-
ing cells relative to WT mice, confirming a hybrid Th1-Th17-cell
phenotype (Figure 2E). Of note, these Th1-Th17 cells retained
high expression of Il12rb2 and Cxcr3 mRNA, equivalent to WT
Th1 cells, while also expressing Il23r (Figure S2E). Genes asso-
ciated with the Th2-cell subset such as Gata3 and Il4 were
also dysregulated in dnRara Th1 cells consistent with a role for
T-bet in repression of GATA3 (Zhu et al., 2012). These findings
show that, in the absence of RA signaling, committed Th1-cell
precursors can give rise to cells with a Th17-cell expression
signature providing a new perspective on the origins of Th1-
Th17 cells. Collectively, these data demonstrate that RA is not
only required for Th1-cell differentiation but is also critical in
suppressing Th17-cell development in Th1 polarized cells.
RA-RARa Is Required for Late-Phase, STAT4-Dependent
T-bet Expression in Th1 Cells
Early expression of T-bet following TCR activation is dependent
on IFN-g, whereas late expression of T-bet (post-termination
of TCR signaling) has been shown to be dependent on IL-12
(Schulz et al., 2009). To distinguish a requirement for RA
signaling in Th1-cell commitment from maintenance of Th1-cell
fate, we examined the kinetics of T-bet expression in naive
CD4+ T cells cultured under Th1 polarizing conditions. Induction
of T-bet was observed with comparable amounts of T-bet
expression between WT and dnRara T cells at day 3 of culture,
indicating that RA-RARa signaling is not required for early Th1
lineage commitment (Figure 3A). However, T-bet expression
was not sustained in dnRara Th1 cells, with substantially dimin-
ished expression of T-bet by day 5 of culture. Given that IFN-g
promotes T-bet expression, the expression of T-bet was exam-
ined in the presence of recombinant IFN-g, in order to avoid
potential indirect effects caused by reduced IFN-g production
in dnRara Th1 cells. Exogenous IFN-g enhanced early T-bet
expression in both dnRara and WT Th1 cells but did not rescue
the late (>72 hr) impairment in T-bet expression (Figure 3A).
IFN-g signaling, as measured by STAT1 phosphorylation, was
not impaired at either time point (data not shown).
The late IL-12-dependent peak of T-bet expression observed in
the presence of blocking IFN-g antibodies was abrogated in
dnRara Th1-cell polarized cells (Figure 3A) suggesting impaired
STAT4 activity. At day 3 of culture, comparable amounts of phos-
phorylated STAT4 (pSTAT4) were observed between dnRara and
WT mice. By contrast, at day 6 of culture, IL-12 induced pSTAT4
wasmarkedly impaired in dnRara T cells (Figure 3B) despite com-
parable expression of IL-12Rb2 mRNA and protein expression
and increased expression of Il12rb1 mRNA (Figure 3C and 3D).
Analysis of Stat4 expression, demonstrated impaired induction
of Stat4 in the absence of RA signaling (Figure 3E) with reduced
amounts of total STAT4 protein (Figure 3F). These findings
suggest that the observed reduction in pSTAT4 in dnRara Th1
cells is a consequence of diminished STAT4 expression. Consis-
tent with deviation toward the Th17-cell lineage, we observed
enhanced pSTAT3 activity in Th1-cell polarized dnRara cells
with an increased ratioofpSTAT3/pSTAT4 (FiguresS3AandS3B).
To evaluate whether the impairment in T-bet and STAT4
expression correlated with changes in IFN-g, the time course





Figure 2. RA Signaling Required for Th1-Cell Differentiation and Repression of Th17-cell Fate in Th1-Cell Precursors
Sorted naive CD4+ T cells from dnRara or WT mice were cultured under Th1 conditions for 6 days.
(A) Intracellular expression of IFN-g and IL-17A following stimulation with PMA and ionomycin.
(B) T-bet and RORgt expression. Grey histograms indicate staining for Tbx21–/– (left panel) or isotype control antibody (right panel). Numbers showMFI. Numbers
in quadrants represent percent cells in each.
C) Amount of IL-17A, IL-21, IL-22, and IL-10 in supernatants following restimulation of cells as in (A) with a-CD3 and a-CD28 for 24 hr as measured by multiplex
bead array. Triplicate culture wells.
(D) Quantitative real time PCR analysis of Th1 and Th17-cell signature cytokine and TF genes following stimulation with PMA and ionomycin.
(legend continued on next page)
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of IFN-g expression following initiation of Th1-cell polariza-
tion was analyzed in naive dnRara-IfngeYFP expressing CD4+
T cells. The kinetics of IFN-g induction, as measured by fre-
quency of eYFP+ cells, closely mirrored WT cells during the first
72 hr of culture but expression was not sustained in the absence
of RA signaling (Figure 3G). Collectively, these data show that RA
plays a temporal role in Th1 differentiation, maintaining Th1-cell
commitment through regulation of T-bet and STAT4.
RA-RARa Regulates Th1-Cell Plasticity
Alterations in thestable expressionof lineage-determiningTFsare
thought to underlie Th-cell stability or plasticity. The emergence of
Th1-Th17 cells together with the loss of T-bet expression, sug-
(E) Naive CD4+ T cells from dnRara-IfngeYFP and IfngeYFP mice were cultured under Th1 conditions. IFN-g (eYFP+) cells were sorted on day 7 following stimulation
with PMA and ionomycin. Heatmaps displaying the fold changes of genes that were differentially expressed (fold change > 1.5, p < 0.05) for selected cytokines or
cytokine receptors (upper panel) and TFs (lower panel). Samples from three independent experiments.
Representative data of at least three (A and B) or two (C and D) independent experiments. Mean ± SEM.





Figure 3. RA Required for Late Phase T-bet
Expression
(A) Naive CD4+ T cells from dnRara and WT mice
were differentiated under Th1 conditions with
combinations of IFN-g or IFN-g antibody. T-bet
expression analyzed at the indicated time points.
Histograms gated on CD4+ T cells.
(B) Flow cytometric analysis of STAT4 phosphor-
ylation in naive CD4+ T cells from dnRara and WT
mice differentiated under Th1 conditions. Cells
analyzed directly from culture after 3 days (left
panel) or on day 6 following treatment with (solid
lines) or without (dashed lines) 25 ng/ml IL-12 for
30 min (right panel). Shaded histogram displays
pSTAT4 staining in cells cultured under Th0
conditions.
(C) Cell-surface expression of IL-12Rb2 on day 6 of
culture.
(D) Quantitative real-time PCR analysis of Il12rb1
and Il12rb2 on day 6.
(E) Quantitative real-time PCR analysis of Stat4
in Th1 polarized cells at indicated time points.
Expression relative to naive CD4+ T cells.
(F) Western blot analysis of total STAT4 protein on
day 6 of Th1 culture.
(G) Naive CD4+ T cells from dnRara-IfngeYFP and
control mice were activated under Th1 conditions.
Frequency of IFN-g+ (eYFP+) cells at indicated
time points, gated on viable CD4+.
Data representative of two to three independent
experiments. Mean ± SEM.
See also Figure S3.
gested a role for RA in the regulation of
Th1-cell plasticity. However, diminished
T-bet and STAT4 activity from day 3 of
primary Th1-cell differentiation prevented
assessment of lineage stability in fully
differentiated Th1 cells. To determine
whether RA-RARa was required for long-
term Th1-cell fate, we differentiated naive
CD4+ T cells from dnRaralsl/lsl mice under Th1-cell conditions,
treated them with TAT-Cre (Wadia et al., 2004) on days 5 and 7,
and restimulated them under Th1-cell conditions for a further
5 days. The temporal loss of RA signaling in Th1 cells resulted in
decreased T-bet expression with a reciprocal increase in RORgt
expression (Figure 4A). !50% of cells expressed RORgt, which
suggests that ongoing RA-RARa activity is critical for sustaining
T-bet and suppressing Th17-cell fate. Alterations in the lineage
determining TFs did not impact on the cytokine phenotype (Fig-
ure S4A). This might in part reflect T-bet independent regulation
of the Ifng locus at late stages in Th1-cell development.
To further examine the role of RA in Th1-cell stability, naive
CD4+ T cells from IfngeYFP mice were differentiated under
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Th1-cell polarizing conditions. eYFP+ (IFN-g+) cells were FACS-
sorted on day 7 of culture and restimulated under Th1-cell con-
ditions in the presence of the RAR inhibitor LE540 (RAi) or vehicle
control (Veh). Inhibition of RA signaling in fully committed Th1
cells propagated for a further 5 days under Th1 conditions re-
sulted in downregulation of T-bet and the emergence of cells
co-expressing RORgt (Figure 4B). Diminished T-bet expression
was associatedwithmodest reductions in IFN-g expression (Fig-
ure S4B). Taken together, these data establish that loss of RA
signaling in fully committed Th1 cells leads to transdifferentiation
to progeny with features of the Th17 lineage and support amodel
where RA constrains late-stage plasticity of Th1 cells.
RA-RARa Regulates Enhancer Activity at Lineage
Determining Th1-Cell Genes
To better understand the molecular mechanism by which RARa
regulates Th-cell fate, we performed genome-wide analysis of
RARa binding in WT Th1 cells by ChIP-Seq, combined with tran-
scriptional profiling of dnRara-expressing Th1 cells in order to
identify functional targets of RARa. Selected loci were validated
by ChIP-qPCR. RARa binding was identified at 1,766 sites in
1,567 genes. RARa binding was detected at 10.3% (76 of 740
genes) of genes downregulated in the absence of RA signaling
(Table S2) (hereafter referred to as positively regulated) and
4.8% (56 of 1,169) of the upregulated genes (Table S3). In keep-
ing with its classical role as a positive regulator of transcriptional
activation there was significant enrichment of RARa binding
at genes positively regulated by RA (Fisher’s exact test, p <
0.0001). However, the presence of RARa at a subset of the nega-
tively regulated genes indicates that RA-RARa also plays a role in
transcriptional repression within Th1 cells.
RA-RARa-dependent loci included Th1-cell lineage-defining
genes (Tbx21 and Stat4-Stat1). In addition to targeting the
Tbx21 promoter (Figures 5A and 5B), modest RARa binding
was observed at the conserved T-bet enhancer element, 12kb
upstream of the transcriptional start site (TSS) (Yang et al.,
2007). This was confirmed by ChIP-qPCR (Figure 5B). Intergenic
A
B
Figure 4. Loss of RA Signaling in Fully
Committed Th1 Cells Leads to Th1 Plasticity
and Divergence Toward the Th17 Lineage
(A) Naive CD4+ T cells from dnRaralsl/lsl mice were
differentiated under Th1 conditions. Th1 cells were
transduced with TAT-Cre on days 5 and 7 and re-
polarized under Th1 conditions for a further 5 days.
Intracellular expression of T-bet and RORgt.
(B) Naive CD4+ T cells from IfngeYFP mice were
differentiated under Th1 conditions. IFN-g (eYFP+)
cells were sorted on day 7 and restimulated under
Th1 conditions for 5 days in the presence of Veh or
RAi. Intracellular expression of T-bet and RORgt.
Data representative of two independent experi-
ments.
See also Figure S4.
RARa was also detected at the Stat4-
Stat1 locus and an Ifng enhancer element
(Figures S5A and S5B).
RA binding to nuclear RARa results in
recruitment of co-activator complexes
containing the histone acetyl-transferases p300 and CBP (Kamei
et al., 1996). p300 is highly enriched at enhancer regions where it
acetylates H3K27, a marker of active enhancers (Rada-Iglesias
et al., 2011), suggesting a possible role for RA-RARa in regulating
enhancer activity. To test this, we mapped genome-wide binding
of p300, H3K4me1, H3K4me3, and H3K27ac histone modifica-
tions in dnRara and WT Th1-cells, validating selected regions by
ChIP q-PCR. Active enhancers were operationally defined as re-
gions with increased intensity of H3K4me1, p300, and H3K27ac
with low or absent H3K4me3 (Rada-Iglesias et al., 2011).
RARa binding at the Tbx21, Stat4, and Ifng loci co-localized
with p300 binding at enhancer regions (Figures 5A and S5A).
dnRARa lacks the activation function 2 (AF2) domain which is
required for RA-dependent recruitment of coactivators. Consis-
tent with this, dnRara expressing T cells exhibited a significant
reduction in p300 occupancy and H3K27ac deposition at the
Tbx21 enhancer, supporting the direct regulation of enhancer
activity by RA-RARa (Figures 5A and 5C). p300 binding at the
Ifng and putativeStat4 intergenic enhancers was also dependent
on RA-RARa (Figures S5A and S5C). Loss of p300 binding at the
Stat4-Stat1 intergenic enhancer in dnRara Th1 cells correlated
with reduced Stat4 transcripts, whereas Stat1 expression was
actually increased, suggesting that this enhancer element regu-
lated Stat4 transcription. A recent study identified a role for
STAT4 in the regulation of Th1 enhancers (Vahedi et al., 2012).
Given that STAT4 expression was reduced in dnRara Th1 cells,
it was possible that the loss of p300 was in part due to reduced
expression of STAT4. To address this issue, we assessed the
binding of STAT4 in WT Th1 cells and compared p300 occu-
pancy in WT and Stat4–/– Th1 cells using publicly available
ChIP-seq data (Table S1) (Vahedi et al., 2012; Wei et al., 2010).
Although STAT4 binding was observed at the Tbx21 enhancer,
loss of STAT4 was not associated with obvious differences in
p300 binding (Figure S5D), arguing for a direct contribution of
RARa to p300 recruitment and enhancer activity. Collectively,
these data show that RA regulates expression of key Th1-cell
lineage genes through remodeling of enhancer regions.
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RA-RARaRepresses Th17-Cell Fate in Th1Cells through
Direct Regulation of Th17-Cell Genes
The earlier finding that Th1 cells acquired features of Th17 cells in
the absence of RA signaling led us to evaluate direct regulation of
Th17-cell-instructing genes by RA-RARa. We first investigated
effects of RA on the Th17-cell pioneer factors BATF and IRF4.
As previously reported (Basu et al., 2013), these genes were ex-
pressed in WT Th1 cells. Strikingly, kinetic analysis of Batf and
Irf4 expression in naive cells stimulated under Th1-cell condi-
tions revealed dramatic upregulation of IRF4 (40- to 60-fold) dur-
ing the initial phase of Th1-cell polarization with comparable
expression between dnRara and WT cells (Figure 5D). Loss of
RA signaling resulted in derepression of BATF-IRF4 target
genes, Rorc, Il23r, Il22, Il21, and Il12rb1 (Figure 5E). This
suggested that ‘‘balancing’’ factors must be induced in an
RA-dependent manner to restrict the actions of BATF-IRF4 com-
plexes at Th17-cell genes. IRF8, an alternative binding partner
for BATF, previously shown to suppress Th17 differentiation
(Ouyang et al., 2011), was one of the RARa target genes most
suppressed in dnRara Th1 cells. In WT Th1 cells, induction of
Irf8 expression paralleled Irf4 expression. However, in dnRara
cells Irf8 expression was not sustained past 24 hr (Figure 5D).
RARa bound at a putative upstream enhancer (Figures 5F and
5G) and in the absence of RA signaling, reduced p300 and
H3K27ac were observed at this locus (Figure 5H and 5I).
Together, these data show that RA directly regulates expression
of IRF8 in Th1 differentiating cells and suggests a potential
mechanism by which BATF-IRF4 activity is constrained within
early Th1 cells.
Transcriptional activation of BATF-IRF4 target genes is depen-
dent on STAT3 and RORgt (Ciofani et al., 2012). Various genes
for cytokines and cytokine receptors associated with STAT3
activation (Il21, Il1r1, Il6ra, and Il23r) were derepressed in dnRara
Th1 cells (Figure 5E). RARa targeted the promoter and an up-
stream enhancer in the Il6ra locus (Figure 5G) with increased
H3k27ac observed at the enhancer element in dnRara Th1 cells
(Figure 5J). Consistent with this, dnRara Th1 cells failed to down-
regulate mRNA and cell-surface IL6-Ra expression during Th1
polarization (Figures S5E and S5F). These findings suggest
that RA regulates Th1-cell plasticity in part by inhibiting respon-
siveness to IL-6.
RORgt was not a direct target of RARa. However, disruption
of RA signaling resulted in increased expression of Runx1, a TF
associated with transactivation of Rorc (Figure S5E) (Zhang
et al., 2008). ChIP analysis confirmed direct regulation of short
and long Runx1 isoform promoters by RA-RARa (Figure 5G).
In Th1 cells, the Rorc locus is epigenetically silenced by T-bet
(Mukasa et al., 2010). However, in dnRara cells, the repressive
H3K27me3 mark was reduced at RORgt isoform-specific exon
(Figure 5K), consistent with loss of T-bet. These findings suggest
that increasedRORgt expression in theabsenceofRARasignaling
is in part due to increased accessibility of the Rorc locus, with un-
restrained activation by Runx1. Collectively these data indicate
that RA-RARa antagonises the activity of the core Th17-cell in-
structing TFs (IRF4, BATF, STAT3, and RORgt), both directly and
indirectly, to suppress the Th17-cell gene program. Notably,
Th2-cell-associated genes were not identified as targets of
RARa (TablesS2andS3) suggesting thatdirect repressionofalter-
native cell fates by RA-RARa is specific to the Th17-cell program.
Th1-like Th17 Cells Emerge during Infection with
L. monocytogenes in the Absence of RA Signaling
To assess the significance of these findings for immune re-
sponses in vivo, we intravenously infected WT and dnRara
mice with an attenuated strain of L. monocytogenes (DActA),
Lm-2W, which allows tracking of CD4+ T cells specific for
listeriolysin O peptide LLO190–201 (LLOp). At the peak of the
response, CD4+ T cells were isolated from the spleen and
LLOp antigen-specific T cells were assayed for expression of
cytokines and the TFs, T-bet, and RORgt. dnRara mice
mounted an effector-T-cell response of similar magnitude to
WT mice with comparable frequencies and total numbers of
CD44hiLLOp:I-Ab-specific CD4+ T cells (Figures 6A and 6B). In
WT mice, Lm-2W induced a Th1-cell restricted response, as
evidenced by high T-bet expression within the LLOp-specific
T-cell fraction (Figure 6C). LLOp:I-Ab+ CD4+ T cells from dnRara
mice expressed lower amounts of T-bet and a substantial
proportion expressed RORgt, with co-expression of these TFs
observed in a subset of cells (Figure 6C). At day 7 post-infec-
tion, a significant proportion of CD4+ T cells isolated from the
spleen of dnRara mice were IL-17+ or dual IL-17A+IFN-g+ with
a trend toward reduced frequency of IFN-g+ cells (Figure 6D).
Measurement of cytokine protein concentrations from spleno-
cytes restimulated with LLOp confirmed reduced amounts of
IFN-g and concomitant increase in IL-17A (Figure S6A). We
did not detect IL-4 production by intracellular staining or protein
secretion (Figure S6A and S6B). Consistent with our in vitro data
showing downregulation of IL6-Ra on WT Th1 cells, cell-sur-
face IL-6Ra was not detectable on WT LLOp:I-Ab+ CD4+
T cells. However, dnRara LLOp:I-Ab+ CD4+ T cells retained
expression of IL-6Ra (Figure S6C), supporting a potential role
for IL-6 signaling in the regulation of Th1-cell plasticity. These
findings establish that RA-RARa signaling in T cells constrains
the emergence of Th17 cells in a Th1-cell-instructing micro-
environment in vivo.
RA Regulates the Th1-Th17-Cell Axis in the Gut and
Prevents the Development of Intestinal Inflammation
RA is constitutively synthesized by a subset of DCs in the gut.
To address the physiological importance of RA signaling
in the regulation of pathogenic intestinal CD4+ T cells, we inter-
bred dnRara mice with OTII mice that transgenically express an
ovalbumin (OVA)-specific TCR and transferred naive CD4+
T cells from OTII(dnRara) or WT OTII mice into Rag1!/! hosts.
Recipients were maintained on an OVA-containing diet for
7 days to induce differentiation within the transferred cells and
migration to the intestinal tissue. Consistent with the infection
experiments, feeding OTII(dnRara)-recipient mice OVA resulted
in a shift in the Th1-Th17-cell balance with a deficiency in IFN-g-
producing cells and increased frequency of IL-17+ and dual
IFN-g+IL-17+ cells in the mesenteric lymph node (MLN), lamina
propria lymphocytes (LPL), and spleen (Sp), 7 days after transfer
(Figures 7B and 7C). To address the functional significance of
the dysregulated cytokine response in dnRara T cells, we orally
challenged mice with OVA and evaluated them for development
of intestinal inflammation and diarrhea (Figure 7A). Recipients of
OTII(dnRara) cells developed accelerated wasting disease rela-
tive to mice that received WT OTII cells (Figure 7D). Whereas all
of the recipients of OTII(dnRara) cells developed severe diarrhea
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by day 12 (Figure 7E), recipients of WT cells remained diarrhea
free. Cytokine production was also assessed after the first
gavage and confirmed an increased frequency of IL-17+ cells
with concomitant reduction in IFN-g+ cells. Notably, enhanced
IL-17 responses were not a consequence of impaired Foxp3+
conversion (Figure 7F). Homing of transferred cells to the gut
was not affected in this model with similar frequencies of
CD4+ T cells detected in the gut tissues (Figure S7A). We
conclude that loss of RA signaling leads to deviation from Th1
to Th17 phenotype both in the periphery and the gut where
these Th17 cells are associated with significant intestinal
inflammation.
Figure 5. RA-RARa Regulates Enhancer Activity at Th1 Lineage Associated Loci and Represses Th17 Genes
Naive CD4+ T cells from WT and dnRara mice were cultured for 6 days under Th1 conditions prior to chromatin precipitation and transcriptional profiling.
(A) ChIP-seq binding tracks at Tbx21 locus for RARa in WT Th1 cells and p300 binding, H3K27ac, H3K4me1, and H3K4me3 modifications in WT and dnRara Th1
cells.
(B) Validation of the RARa-binding regions in WT Th1 cells by ChIP-qPCR. Untr6 region serves as a negative control. Binding events per 1,000 cells displayed as
‘‘Enrichment.’’
(C) The effects of dnRara expression on p300 and H3k27ac abundance at the Tbx21 locus were validated by ChIP-qPCR.
(D) Quantitative real-time PCR analysis ofBatf, Irf4, and Irf8mRNA in naive CD4+ T cells from dnRara orWT cells differentiated under Th1-cell conditions for 0, 24,
48, 72 hr. Mean ± SEM, replicate wells.
(E) Log2 values of fold changes in gene expression as measured by microarray analyses. Average fold change depicted.
(F) ChIP-seq binding tracks at Irf8 locus for cells as in (A).
(G) Validation of RARa ChIP-seq regions by ChIP-qPCR.
(H–J) ChIP analysis of p300 and H3K27ac at selected loci.
(K) ChIP analysis of H3K27me3 at the RORc locus. Actb locus serves as a negative control.
Data from three independent experiments (E) or representative of two independent experiments (B–D, G–K); Mean ± SD unless noted otherwise. Abbreviation:
pro, promoter.




Figure 6. RA Signaling Required to Prevent
the Generation of Th17 Cells during Infec-
tion with L. monocytogenes
(A) Frequency of LLOp:I-Ab CD4+ T cells isolated
from spleen of dnRara and WT mice 7 days
after infection with an attenuated strain of
L. monocytogenes (Lm-2W). Gated on CD4+
T cells.
(B) Absolute numbers of LLOp:I-Ab CD4+ T cells
as in (A).
(C) Intracellular T-bet and RORgt expression gated
on LLOp:I-Ab CD4+ T cells.
(D) Intracellular staining for IFN-g and IL-17A
following stimulation of splenocytes with LLOp for
6 hr, 7 days after infection with Lm-2W. Gated on
CD4+ T cells. Right panel shows statistical data
pooled from three independent experiments (3–6
mice per group).
Representative data of at least three (A and B), or
two independent experiments (C). Mean ± SEM.
See also Figure S6.
DISCUSSION
Dysregulated Th-cell responses underlie
the pathogenesis of autoimmune and
allergic disease. In contrast to T regulato-
ry (Treg) cells and Th17 cells, the Th1-cell
lineage is thought to be relatively stable.
However, the factors that control mainte-
nance of the Th1-cell lineage were not
previously known. This study identifies RA-RARa as a central
regulatory node in the transcriptional network governing Th1-
cell stability. We found that RA-RARa directly sustained the
expression of lineage determining Th1-cell-associated genes
during naive T-cell differentiation while also repressing signature
Th17-cell-associated genes. Ablation of RA signaling in Th1-
committed cells resulted in enhanced Th1-cell plasticity with
deviation towards a Th17-cell phenotype. Using ChIP-seq to
identify regulatory elements, we found that RARa bound at en-
hancers and recruitment of p300 to these regions was depen-
dent on RA signaling. In vivo, both Th17 and Th1-Th17 cells
emerged during infection with L. monocytogenes and in a model




Figure 7. Loss of RA Signaling Causes Dysregulated Th1 and Th17 Response and Increased Pathogenicity in a Model of Gut Inflammation
(A) Schematic illustration of the adoptive transfer experiment.
(B) Intracellular expression of IL-17A and IFN-g among CD4+ cells from the spleen (Sp), mesenteric lymph nodes (MLN), and lymphocytes from the lamina propria
(LPL) of mice as in (A) 7 days after transfer.
(C) Statistical data for frequency of IFN-g+, IL-17+, and IFN-g+IL-17+ cells as in (B) in MLN and Sp.
(D) Percentile change of original body weight in Rag1!/! recipients treated as in (A) (n = 5–7 per group). Mean ± SD.
(E) Frequency of diarrhea-free mice among Rag1!/! recipients as in (A) (OTII recipients n = 3, OT-II(dnRara) recipients n = 5).
(F) Frequencies of IL-17, IFN-g, and Foxp3 in CD4+ cells isolated from Sp, MLN, LPL, and IELs of mice as in (A), 9 days after transfer (n = 5 or 6 per group).
Data from one experiment (B and C), pooled from two independent experiments (D and F), or representative of two independent experiments (E). Mean ± SEM
unless otherwise noted.
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of oral tolerance. In the latter, their presencewas associated with
significant pathology.
Enhancers play a key role in directing cell fate through the
regulation of lineage specifying genes. Enhancer profiling in
WT and dnRara T cells revealed RA-dependent activation of en-
hancers at genes critical for Th1 identity (Tbx21, Stat4, Ifng, and
Irf8). RA-dependent changes in p300 and H3K27ac were re-
flected at the transcriptional level suggesting that, in addition
to its classical role as a transcriptional regulator, RA regulates
gene expression in an enhancer-dependent manner. Although
the ability of RA-RARa to target p300-CBP complexes to nucle-
osomes is well established, regulation of enhancers by RA has
not been widely studied. We propose that unliganded RARa at
enhancer elements acts as a gatekeeper, enabling initiation of
enhancer activation once T cells sense RA in the microenviron-
ment. A similar role has been demonstrated for STAT proteins
(Vahedi et al., 2012), suggesting that environmental cues act
as checkpoints for initiation of enhancer activation and T-cell
fate. Although H3K4me1 modifications are present at early
time points during T-cell differentiation, conversion to ‘‘active’’
status requires acquisition of H3K27ac, which is often not
evident until later stages of differentiation (Hawkins et al.,
2013). Consistent with a temporal role for enhancers in mainte-
nance of gene expression, RA signaling was not required for initi-
ation of transcription of target genes but rather acted to maintain
their expression. These data highlight the importance of en-
hancers in maintenance of cell identity and plasticity. It is
possible that RA-RARa regulation of enhancers represent the
major mechanism by which RA regulates cell fate. A recent study
identified enrichment of RARa at enhancers in embryonic stem
cells (Chen et al., 2012). Given that the RA-RARa axis is a highly
conserved signaling pathway, which plays a critical role in regu-
lating cell-fate specification during embryogenesis and cell dif-
ferentiation, it will be important to evaluate a broader role for
RA-RARa in regulation of enhancer functionality, both in alterna-
tive Th-cell subsets and outside of the immune system.
In addition to sustaining expression of Th1-cell-associated
genes, we found that RA actively silences genes implicated in
Th17-cell differentiation. Among genes known to regulate the
Th17-cell program, Runx1 and Il6ra were directly repressed by
RA-RARa. In addition, BATF-IRF4 target genes were dere-
pressed in the absence of RA signaling. In Th17 cells, BATF-
IRF4 complexes act co-operatively as pioneer factors at key
Th17 genes (Ciofani et al., 2012), modulating chromatin accessi-
bility to facilitate binding of STAT3 and RORgt. On the basis of
their expression in alternative Th-cell subsets, it has been sug-
gested that BATF-IRF4 complexes play a universal role in estab-
lishing binding of lineage-specific TFs (Ciofani et al., 2012).
However, BATF deficiency does not impact on Th1-cell differen-
tiation (Schraml et al., 2009). An alternative model is that upregu-
lation of BATF and IRF4 confers plasticity in early Th1 cells,
poising chromatin specifically at Th17-cell-associated genes.
IRF8, an alternative binding partner for BATF, negatively regu-
lates Th17-cell differentiation (Ouyang et al., 2011). Our results
identified IRF8 as a member of the Th1-cell transcriptional
network whose expression was critically dependent on RA
signaling. Induction of IRF8 would be expected to limit plasticity
of Th1 cells by repressing Th17 differentiation, potentially by
competing for binding to BATF. In support of a role for IRF8 in
regulation of Th1-Th17 axis, patients with mutations in IRF8
have impaired Th1 responses (Hambleton et al., 2011) and single
nucleotide polymorphisms (SNPs) in Irf8 are associated with
several autoimmune diseases in which IFN-g+ Th17 cells play a
pathogenic role (Franke et al., 2010; Cunninghame Graham
et al., 2011). It will be of interest to identify transcriptional targets
of BATF, IRF4, and IRF8 in Th1 cells.
RA signaling was critical to maintain appropriate Th1-cell
responses and suppress the development of IL-17+ and IFN-
g+IL17+ cells. Hybrid Th1-Th17 cells are implicated in the patho-
genesis of several autoimmune diseases. Their development has
been attributed to the plasticity of Th17 cells. Our findings sug-
gest that these cells might alternatively reflect Th1 plasticity
and suggest a novel developmental pathway for Th17 cells.
Th1 derived ‘‘Th17’’ cells expressed high levels of the receptor
for IL-23, a critical determinant of Th17 pathogenicity (Basu
et al., 2013), and were associated with significant gut inflamma-
tion and pathology in a model of oral tolerance. Further experi-
ments are required to test the prediction that pathogenic Th17
and IFN-g+IL-17+ cells which arise in autoimmunity emerge
from Th1 cells when RA is deficient or its signaling perturbed.
A range of inflammatory stimuli can induce RA synthesis and
signaling during the course of an immune response. Our results
suggest that in a Th1-cell instructing microenvironment the
dominant action of RA is to repress Th17-cell fate and promote
Th1-cell responses. We did not observe enhanced Th17-cell
responses during primary Th17-cell differentiation, suggesting
that the impact ofRAonT-cell stabilitymight varyboth temporally
and among tissues. Previously we have shown in a model of skin
allograft rejection that impaired Th1 responses in dnRara mice
were accompanied by increased Th2-cell cytokines (Pino-Lagos
et al., 2011). We did not identify direct repression of Th2-cell-as-
sociated genes by RARa. However, T-bet suppresses GATA3
(Zhu et al., 2012) and in the presence of a Th2 skewing micro-
environment, such as the skin, impaired expression of T-bet in
the absence of RA signaling renders cells susceptible to Th2 de-
viation. Thus, the effects of RA on T-cell fate are likely dependent
on external and intrinsic factors that shape T-cell polarity.
In summary, we show that RA signaling plays a critical role in
regulating stability and functional plasticity of Th1 cells. Regula-
tion of enhancer activity at lineage determining genes by RA-
RARa provides mechanistic evidence for reciprocal regulation
of Th1 and Th17-cell programs. In the absence of RA signaling,
downmodulation of T-bet, STAT4, and IFN-g, and loss of repres-
sion of Th17-cell genes, creates a permissive environment for
transdifferentiation of Th1 cells to Th17 cells. This study iden-
tifies the RA-RARa axis as a potential node for intervention in




C57Bl/6 dnRara mice have been described previously (Pino-Lagos et al.,
2011). IfngeYFP (GREAT) mice were purchased from the Jackson Laboratory.
Mice were bred and maintained at Charles River Laboratory, UK, in path-
ogen-free conditions. All animal experiments were conducted in accordance
with the UK Animals (Scientific Procedures) Act 1986. C57Bl/6 OTII(dnRara),
OTII, andRag1!/!micewere bred andmaintained at the Rockefeller University
specific pathogen-free animal facility.
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Cell Isolation, Cell Culture, and Flow Cytometry
Sort purified, naive CD4+CD25–CD44loCD62Lhi T cells were cultured with T-cell
depleted splenocytes (APCs) and anti-CD3 under polarization conditions for
Th0, Th1, Th2, and Th17-cell-associated subsets. Details are provided in the
Supplemental Experimental Procedures. For analysis of cytokine production,
cells were restimulated with 100 ng/ml phorbol 12-myristate 13-acetate (PMA)
and 500 ng/ml ionomycin in the presence of monensin for 4–5 hr at 37!C. Cells
were stained with LIVE/DEAD Dead Cell Stain (Invitrogen), followed by staining
for cell-surface markers and then fixed and permeabilized (BD Biosciences)
for staining of intracellular antigens. Flow cytometry was performed on a LSR
Fortessa (BD Biosciences) and analyzed with Flowjo software (Tree Star).
TAT-Cre Transduction
Sort purified naive CD4+ T cells were differentiated under Th1 conditions. After
5 days, cells were treated with 50 mg/ml TAT-Cre peptide for 45 min at 37!C,
then washed and expanded in IL-2-containing medium. After 48 hr cells
were retreated with Tat-Cre followed by polarization under Th1 conditions.
Real-Time Quantitative PCR
Total RNA was extracted from cells with RNeasy Mini kit (QIAGEN) and cDNA
was synthesized with Qscript RT kit (Quanta). Quantitative gene-expression
analysiswasperformedusingTaqmanprimer probe sets (AppliedBiosystems),
listed in Table S4. Expression of target genes was normalized to b-actin.
Microarray Gene-Expression Profiling
For gene-expression analysis Affymetrix (for IfngeYFP dataset) or Agilent (for
the dnRara Th1 dataset) microarray chips were used. Differentially expressed
genes were detected using fold-change and t test analysis. See Supplemental
Experimental Procedures for further information.
Chromatin Immunoprecipitation and ChIP-Seq
Immunoprecipitation and DNA sequencing was performed by Active
Motif. The following antibodies were used: anti-H3K27me3 (Millipore 07–
449), anti-p300 (Santa Cruz sc–551X), anti-H3K4me1 (Active Motif 39287),
anti-H3K4me3 (Active Motive 39159), anti-H3K27ac (active Motif 39133),
anti-RARa (Diagenode C15310155). Illumina sequencing libraries were pre-
pared from the ChIP and Input DNAs. For ChIP q-PCR, enrichment calculated
as binding events per 1,000 cells using Active Motif’s normalization scheme.
Detailed methods for ChIP-seq and binding site analyses are provided in the
Supplemental Information.
L. monocytogenes Infection
Mice were infected i.v. with 1 3 106 cfu L. monocytogenes and spleens were
harvested 7 days later. Splenocytes were enriched for CD4+ T cells with a
CD4+ T-cell negative selection microbead kit (Miltenyi Biotec) and stained
with PE labeled, LLO:I-Ab dextramer (Immudex) and cell-surface antibodies.
For analysis of intracellular cytokine production, splenocytes were restimu-
lated with LLO peptide (PiProteomics) at 10 mg/ml for 6 hr.
Food-Antigen-Induced Diarrhea Model
Naive CD4+ T cells from OTII or OTII(dnRara) were intravenously transferred
to Rag1"/" mice. These mice were then maintained on a diet containing
OVA for 7 days and challenged with oral OVA on days 9 and 10. Lymphocytes
were isolated from the intestinal epithelium, lamina propria, MLN, and spleen
at the indicated time points after the start of oral OVA exposure of the recipient
mice. Detailed experimental procedures are described in the Supplemental
Experimental Procedures.
Statistical Analysis
Statistical significance was calculated by unpaired two-tailed Student’s t test
with Graphpad Prism software. p values < 0.05 were considered significant.
p values are denoted in figures as follows: *, p < 0.05; **, p < 0.01; ***, p <
0.001; ****, p < 0.0001.
ACCESSION NUMBERS
Chip-seq and microarray data are available under GEO accession number
GSE60356.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, five tables, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.immuni.2015.02.003.
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!Figure S1 (related to Figure 1). Expression of Foxp3 in CD4+ T-cells deficient in RA 
signaling  
(A) Intracellular expression of Foxp3 in CD4+ T-cells from spleen, thymus and mesenteric 
lymph nodes (MLN) of wild-type littermate control (WT) and dnRara mice.  
(B) Total number of CD4+Foxp3+ T-cells in spleen (upper panel) and thymus (lower panel) 
of WT and dnRara mice  



























































!Figure S2 (related to Figure 2). Proliferation and differentiation of CD4+ T-cells in the 
absence of RA signaling  
(A) Naïve CD4+ T-cells from WT and dnRara mice were labeled with CellTraceTM and 
cultured under Th1 conditions for 5 days. Flow cytometry showing dye dilution, gated on 
viable CD4+ T-cells.  
(B) Cell-surface expression of CD44 and CD25 on naïve CD4+ T-cells from WT or dnRara 
mice cultured under Th1 conditions for 5 days. 
(C) Naïve CD4+ T-cell from WT and dnRara mice were cultured under Th0 or Th2 
conditions for 6 days. Cells were analysed by flow cytometry for expression of intracellular 
RORγt. Gated on CD4+ T-cells.  
(D) Sorted naïve CD4+ T- cells from WT and dnRara mice were cultured under Th17 
conditions for 6 days. Intracellular IL-17A and IFN-γ expression after stimulation with PMA 
and ionomycin. 
(E) CD4+ T-cells from dnRara-IfngeYFP and IfngeYFP mice were cultured under Th1 
conditions. Quantitative real-time PCR analysis of Cxcr3 and Il12rb2 from IFN-γ+ (eYFP+) 
cells sorted on day 7. Samples from three independent experiments. 























































































!Figure S3 (related to Figure 3). STAT3 and STAT4 activity in dnRara Th1 
differentiated cells  
(A) Flow cytometric analysis of STAT3 and STAT4 phosphorylation in naïve CD4+ T-cells 
from dnRara and WT mice differentiated under Th1 conditions. Cells analysed after 6 days 
following treatment with 25ng/ml IL-12, 20ng/ml IL-6 and 10ng/ml IL-23 for 30 minutes. 
Dashed lines represent untreated cells. 

































!Figure S4 (related to Figure 4). Cytokine analysis following temporal inhibition of RA 
signaling in Th1 cells  
(A) Naive CD4+ T-cells from dnRaralsl/lsl mice were cultured under Th1 conditions. Th1 cells 
were transduced with TAT-Cre on days 5 and 7 and repolarised under Th1 conditions for a 
further 5 days. Intracellular expression of IFN-γ and IL-17A following PMA and ionomycin 
stimulation. 
(B) Naive CD4+ T-cells from IfngeYFP mice were differentiated under Th1 conditions. IFN-γ+ 
(eYFP+) cells were sorted on day 7 and recovered cells underwent secondary 
repolarisation in Th1 conditions for 5 days in the presence of Veh or RAi.  Intracellular 
expression of IFN-γ and IL-17A following PMA and ionomycin stimulation. 
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!Figure S5 (related to Figure 5). RA-RARα regulates enhancers at Th1 genes and 
represses Th17 lineage specifying genes  
Naive CD4+ T-cells from dnRara and WT mice were cultured under Th1 conditions as in 
Figure 5. After 6 days, ChIP was performed with the specified antibodies, followed by real-
time PCR analysis at selected sites (B-C) or sequencing (A).  
(A) ChIP-seq binding tracks at Stat4 and Ifng loci for RARα in WT Th1 polarised cells and 
p300 binding, H3K27ac, H3K4me1 and H3K4me3 modifications in WT and dnRara Th1 
cells.  
(B) Validation of the RARα ChIP-seq regions in (A) by ChIP-qPCR assays. Untr6 region 
serves as a negative control. Data presented normalised to input.  
(C) ChIP analysis of the abundance of p300 at the loci in (B) in WT and dnRara Th1 cells. 
Data presented normalised to input.  
(D) ChIP-seq analysis of STAT4 binding at the Tbx21 enhancer and comparison of p300 
binding in WT and STAT4–/– Th1 cells. ChIP-Seq data (Vahedi et al. 2012 and Wei et al., 
2010) was mapped to the Dec. 2011 (GRCm38/mm10) mouse genome assembly with the 
UCSC genome browser along with the ChIP-seq binding track for RARα at the Tbx21 
locus.  
(E) Quantitative real time PCR analysis of selected genes identified as differentially 
expressed on genome wide transcriptional profiling analysis of cells as in (A). Mean ± 
SEM. 
(F) Cell-surface expression of IL6-Rα by flow cytometry in naïve dnRara and WT CD4+ T-
cells at indicated timepoints. Grey histogram indicates staining for isotype control.  
Data (B-F) representative of two to three independent experiments. Mean ± SD unless 
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!Figure S6 (related to Figure 6). Cytokine production by dnRARa T-cells following 
infection with L. monocytogenes  
(A) Splenocytes from dnRara and WT mice infected with Lm-2W were restimulated with 
LLOp for 24 h. Concentration of IFN-γ, IL-17A and IL-4 in supernatants was measured by 
multiplex bead array (Biorad). Data normalised to total numbers of CD4+ T-cells. n = 3-4 
mice per group. 
(B) Intracellular staining for IFN-γ and IL-4 following stimulation of splenocytes with LLOp 
for 6 h, 7 days after infection with L. monocytogenes. Gated on CD3+CD4+ T-cells 
(C) Cell surface expression of IL-6Rα by flow cytometry  
on LLOp:I-Ab CD4+ T-cells isolated from spleen of dnRara or WT mice 7 days after 
infection with L. monocytogenes. Data from 4 pooled mice. Numbers indicate MFI. 



































































!Figure S7 (related to Figure 7). Gut homing in dnRara-OTII CD4+ T-cells  
(A) Percentage of OTII or OTII(dnRara) CD4+ cells recovered from LPL, IEL, MLN and 
Spleen of RAG–/– recipients, 9 days after adoptive transfer (n = 3-4 per group).  


























!Table S1 (related to Figure 5). List of Sequencing-Based Data Used in This Study 
including publically available data as indicated by Geo Accession Number 
Samples Non-redundant tags Peak counts 
RARA_WT 13303876 1776 
H3K4me1_DNRAR 18605274 65960 
H3K4me1_WT 23760603 49542 
H3K4me3_DNRAR 18333386 49505 
H3K4me3_WT 21918629 53135 
H3K27Ac_DNRAR 17421600 37788 
H3K27Ac_WT 20513640 37151 
H3K27me3_DNRAR 30667883 56002 
H3K27me3_WT 20833021 78511 
p300_DNRAR 23023765 30495 
p300_WT 25213927 46191 
Stat4 WTTh1 (GSM550303) 8982352 20862 
p300 WT Th1 (GSM994508) 19652779 25554 
p300 Stat4-/- Th1 
(GSM994509) 18282554 29208 
 
Table S2 (related to Figure 5). Genes downregulated in dnRara Th1 cells that were 
bound by RARα in WT Th1 cells. 
1110037F02Rik Fli1 Ncln 
1810011H11Rik Fmnl3 Nedd4l 
3300005D01Rik Foxo3 Nfic 
5830416P10Rik Foxp1 Nln 
Acsl4 Furin Nme1 
Adora2a Gas5 Nod1 
Alkbh7 Gcsh Notch2 
Asb2 Gfi1 Nt5e 
Birc5 Gimap3 P2rx7 
Blm Gimap4 Pde2a 
Bre Gimap8 Prr5l 
Capzb Gimap9 Rbks 
Chsy1 Hic1 Rcbtb2 
Cmas Hmgcs1 Shf 
Cnga1 Idi1 Slc16a6 
Coq7 Ifngr1 Smad3 
Ctps Ifrd2 Sqle 
Cycs Irf8 Sulf2 
!Cyp51 Itih5 Tbx21 
Cyp51 Kcnn4 Treml2 
Dennd4a Kif2c Txn2 
Dusp6 Lbr Ube2e3 
E2f3 Lef1 Uchl3 
Enpp4 Mdc1 Vav3 
Fasn Me2 Vipr1 
Fgl2 Mrto4  
 
Table S3 (related to Figure 5). Genes upregulated in dnRara Th1 cells that were 
bound by RARα in WT Th1 cells 
1110038F14Rik Ifngr2 Slfn2 
Ak2 Il15ra Socs1 
Antxr2 Insr Sp100 
Aph1b Irf1 Stat1 
Arhgap25 Irgm1 Tagap 
Arid4a Kif3b Tmem50a 
B2m Mcl1 Tnip1 
Bace2 Mettl8 Tor1aip2 
Bcl10 Mga Traf1 
Bcl6 Mpeg1 Trpm6 
Birc3 Nek6 Twsg1 
Cd320 Net1 Usp53 
Cnnm2 Npc2 Vav1 
Ddit3 Plec Wdsub1 
Egr2 Polg Zbp1 
Fam43a Ptpn1 Zfp207 
Filip1l Rab19 Zfp36l2 
Fndc3a Rhd Zmym6 
Fuca1 Slamf1  
 
Table S4. Taqman assays used for RT-PCR gene expression analyses (related to 
Figures 1-3 and 5). 
Mouse ACTB  4352341E 
Il6ra  Mm00439653_m1 
Il22  Mm00444241_m1 





Il21  Mm00517640_m1 
Il10 Mm00439616_m1 
Irf8  Mm00492567_m1 
Irf4 Mm00516431_m1 
Stat4 Mm00448890_m1 
Il12rb2  Mm00434200_m1 
Ifng Mm00801778_m1 
Il12rb1  Mm00434189_m1 
Rorc  Mm01261022_m1 
Gata3  Mm00484683_m1 
Tbx21 Mm00450960_m1 
 
Table S5 (related to Figure 5). Sequences of PCR primers used in ChIP assays 
 
Stat4_+105k F TCCTCCTCCCTTTGTTGTTC 
Stat4 +105k R GGGCCTTAATCAACCATTTC 
Stat4 Promoter F AGAGGGCATACACCGAGAAC 
Stat4 Promoter R TCTAGGGAGCCAGCATCAAC 
Tbx21 Promoter F TCGCTTTTGGTGAGGACTG 
Tbx21 Promoter R GGTGGCAGGTTGACTCTTTC 
Tbx21 -12k F GCGGAAGAGGGAACTAACAC 
Tbx21 -12k R GGACCCGGAACCTATGTATG 
Irf8 Promoter F CAGAAGCTAGGGCTGGTGTC 
Irf8 Promoter R CACAGAACAGATCCCAAATGTC 
Irf8 -11k F CCTTAACCCCGGAACTGTAG 
Irf8 -11k R TGCTGTGCTTGCCTCTACTC 
Il6ra Promoter F TCCGCTTGAGTTTTGCTTTC 
Il6ra Promoter R CACTGACCTGCCTTCTACTTTAAC 
Il6ra +32k F CAAAGCTAAAACCAGGAAATGAC 
Il6ra +32k R AAAAGGTTCCATGTGATGTTG 
Rorc Promoter (Rorγt isoform) F AGGAATTTGGGTGTGGTGAG 
Rorc Promoter (Rorγt isoform) R CTGTCTTGGGTGGTGTCTTG 
Runx1 Promoter 1 F TGGAAGAGGAAGAAGCTGTG 
Runx1 Promoter 1 R CAAGAGAAGCCACCCCAAAC 
Runx1 Promoter 2 F TGCTGGGCTTACACTTCTGAC 
Runx1 Promoter 2 R TGGACCTCATAAACAACCACAG 
IFNg +28k F CTTTGAGCCACTGATGGGTAG 
IFNg +28k R GCCTCTCCACGTCTCTTCTTC 
 
  
!Supplemental Experimental Procedures  
 
Reagents  
LLO190-201 was synthesised by PiProteomics and was >95% pure, as determined by HPLC. 
LLO:I-Ab monomers were provided by NIH Core Tetramer Facility. PE labeled LLO:I-Ab 
dextramers were synthesised by Immudex. Recombinant Lm-2W strain was provided by 
Marc Jenkin’s Laboratory. LE540 was purchased from Alpha Laboratories. 
 
Naïve CD4+ T-cell isolation and culture 
Naïve CD4+CD25negCD44loCD62Lhi T-cells were isolated by cell sorting by FACSAria (BD) 
after enrichment with a CD4+ T-cell negative selection kit (Miltenyi Biotec). T-cell depleted 
splenocytes were prepared using a CD3+ microbead selection kit (Miltenyi Biotec) followed 
by irradiation at 3000 rad. Naïve CD4+ T-cells were cultured for 3 days with irradiated 
T cell-depleted splenocytes at a ratio of 1:5 in the presence of 5 µg/ml of anti-CD3 (145-
2C11) under Th0 cell conditions (IL-2 100 IU/ml, anti-IL-4 (11B11) and anti-IFN-g 
(XMG1.2), 10 µg/ml each); Th1 cell conditions (100 IU/ml of IL-2, 10 ng/ml of IL-12, and 
anti-IL-4); Th2 cell conditions (100 IU/ml of IL-2, 10 ng/ml of IL-4, anti-IL-12 (C17.8), and 
anti-IFN-γ (XMG1.2); or Th17 cell conditions, 5 ng/ml TGFβ, 20 ng/ml IL-6, 10 ng/ml IL-1β, 
anti-IL-4, and anti-IFN-γ).  Cells were expanded for an additional 3-4 days. Where 
indicated, 10 ng/ml IFN-γ or 10 µg/ml anti-IFN-γ was added. In secondary repolarisation 
assays, where specified, LE540 (1 µM) or DMSO (vehicle control) was added to the media. 
Cytokines were from R&D. Anti-CD3 was from BioXcell and other antibodies were from BD 
Biosciences. All cell cultures were performed in complete RPMI containing 10% fetal 
!bovine serum (FBS), 55 µM β-mercaptoethanol, HEPES, non-essential amino acids, 
glutamine, penicillin and streptomycin. 
 
TAT-Cre transduction 
Sort purified naïve CD4+ T-cells were differentiated under Th1 conditions. After 5 days, 
cells were washed twice in serum free medium prior to treatment with 50 µg/ml TAT-Cre 
(Millipore) or medium alone (mock treatment). Cells were incubated at 37°C for 45 minutes. 
The reaction was quenched with medium containing 20% FBS followed by further washing. 
Cells were expanded for 2 days followed by retreatment with TAT-Cre or media as before. 
Cells were then restimulated under Th1 cell conditions for 3 days and expanded for a 
further 2 days prior to analysis.  
 
Flow Cytometry 
For analysis of cytokine production, cells were restimulated with 100 ng/ml phorbol 12-
myristate 13-acetate (PMA) and 500 ng/ml ionomycin in the presence of monensin for 4-
5 h at 37oC in a tissue culture incubator. Cell surface staining was carried out in PBS with 
2% FBS. For live cell analysis or cell sorting, dead cells were excluded by staining with 
SYTOX blue (Invitrogen). For intracellular staining, cells were first stained with LIVE/DEAD 
Fixable Violet or near IR Dead Cell Stain (Invitrogen), followed by staining for cell-surface 
markers and then resuspended in fixation/permeabilisation solution (Cytofix/Cytoperm kit 
or Transcription Factor Buffer kit; BD Bioscences). Intracellular staining carried out in 
accordance with the manufacturer’s instructions. Intracellular phosphorylated STAT 
proteins were stained with Phosflow Lyse/Fix Buffer, and Phosflow Perm Buffer III (BD 
!Biosciences) according to the manufacturer’s protocol. Data were collected with a LSR 
Fortessa (BD) and results were analyzed with FlowJo software (Tree Star). All the 
antibodies for staining cell surface markers, cytokines or transcription factors were 
purchased from either BD Biosciences or eBiosciences.  
 
Luminex Immunoassays 
Cytokine levels in supernatants were measured using a multiplex bead-based assay (Bio-
Rad Laboratories) in a Luminex FlexMap3D System (Luminex Corporation).  
 
Western Blotting 
Differentiated Th1 cells were lysed in RIPA buffer supplemented with protease inhibitors. 
Lysates were electrophoresed on 10% gels (Biorad), transferred to nitrocellulose and 
blotted with anti-STAT4 or anti-actin followed by anti-rabbit-horseradish peroxidase 
conjugated antibody. All antibodies were from Cell Signaling Technology. 
 
L. monocytogenes infection and analysis 
Mice were infected i.v. with 1 x 106 cfu L. monocytogenes and spleens were harvested 7 
days later. For FACS analysis, single cell suspensions were enriched for CD4+ T-cells with 
a CD4+ T-cell negative selection microbead kit (Miltenyi Biotec) and stained with PE 
labeled, LLO:I-Ab dextramer (Immudex) and cell surface antibodies. For analysis of 
cytokine production, supernatants were collected from splenocytes restimulated with LLO 
peptide (PiProteomics) at 10 µg/ml for 24 h or intracellular cytokine staining was performed 
following stimulation with LLO peptide for 6 h in the presence of monensin.  
! 
Food antigen induced diarrhoea model 
Rag1–/– mice were kept on a sulfatrim-containing diet and only exposed to autoclaved 
supplies. Naïve OTII CD4 cells (defined as CD4+CD25–Vb5+Va2+CD44-) were sorted from 
8-12 weeks old female C57Bl6 OTII(dnRara) or C57Bl6 OTII mice using a FACS Aria cell 
sorter (Becton Dickinson), and 2 x 106 cells in 100µl PBS were retro-orbitally transferred to 
12 weeks old Rag1–/– females. 12h after the adoptive transfer, the drinking water was 
replaced by a 1% Grade II ovalbumin (OVA, Sigma) and 0.5% Splenda (McNeil 
Nutritionals) solution for 7 days. Body weight was measured at 5pm every day. For 
monitoring diarrhea development, the faeces texture after 7 days of OVA, 2h after a 
gavage challenge with 50mg Grade III OVA (Sigma) in 200 µl PBS on days 9 and 10 and 
without further challenge on day 12 was analysed. A mouse was diagnosed with diarrhoea 
if the faeces had the characteristic soft and light appearance at two consecutive occasions. 
For the single gavage challenge experiment, mice were subjected to the challenge on day 
9 only and the faeces were analysed after 2h. To determine T cell frequencies, 
lymphocytes were isolated as previously described (Mucida et al., 2007) on day 7 (from 
mesenteric lymph node (MLN) and spleen only) or day 9 (from the intestinal epithelium, 
lamina propria, MLN and spleen) after the start of oral OVA exposure of the recipient mice. 
For cytokine staining, isolated lymphocytes were stimulated for 3h in RPMI medium 
supplemented with 10% FBS, 55 µM β-mercaptoethanol, 100ng/ml PMA (Sigma), 
500ng/ml Ionomycin (Sigma) and 10µg/ml brefeldin A (Sigma) prior to the incubation with 
antibodies. Cells were first stained with antibodies against cell surface markers, followed 
by permeabilization using either Fix/Perm buffer (BD Pharmingen) for cytokine stainings, or 
!using the Foxp3 Mouse Regulatory T cell Staining Kit (eBioscience) for Foxp3 staining. 
The fluorescent-dye- conjugated antibodies used were obtained from BD-Pharmingen 
(anti-CD4, 550954; anti-CD25, 553866; anti-IL-17a, 559502; anti-Vb5, 553190) or 
eBioscience (anti-CD44, 56-0441; anti-CD45.2, 47-0454; anti-TCR-β, 47-5961; anti-IFN-γ, 
25-7311; anti-Foxp3, 17-5773; anti-Vα2, 48-5812). Stained cells were analysed using a 
LSR-II flow cytometer (Becton Dickinson) and population frequencies were determined 
using the FlowJo software (Tree Star). 
 
Chromatin immunoprecipitation (ChIP) 
20-60 million Th1 polarised cells from WT and dnRara mice were fixed, washed and snap-
frozen according to the Cell Fixation protocol from Active Motif 
(http://www.activemotif.com/documents/1848.pdf). Chromatin was isolated by the addition 
of lysis buffer, followed by disruption with a Dounce homogenizer. Lysates were sonicated 
and the DNA sheared to an average length of 300-500 bp. Genomic DNA (Input) was 
prepared by treating aliquots of chromatin with RNase, proteinase K and heat for de-
crosslinking, followed by ethanol precipitation. Pellets were resuspended and the resulting 
DNA was quantified on a NanoDrop spectrophotometer. Extrapolation to the original 
chromatin volume allowed quantitation of the total chromatin yield. An aliquot of chromatin 
was precleared with protein A agarose beads (Invitrogen). Following immunoprecipitation 
with specified antibodies, complexes were washed, eluted from the beads with SDS buffer, 
and subjected to RNase and proteinase K treatment. Crosslinks were reversed by 
incubation overnight at 65 C, and ChIP DNA was purified by phenol-chloroform extraction 
!and ethanol precipitation and used for the preparation of Illumina sequencing libraries and 
for ChIP qPCR analysis. 
 
ChIP-qPCR 
Quantitative PCR (qPCR) reactions were carried out in triplicate on specific genomic 
regions using SYBR Green Supermix (Bio-Rad).  See Table S5 for Primer details. The 
resulting signals were normalized for primer efficiency by carrying out qPCR for each 
primer pair using Input DNA. By using standards of known quantities of DNA it was 
possible to calculate the number of genome copies pulled down for each of the sites 
tested, and thus to calculate the copies pulled down per starting cell number, presented as 
‘Enrichment’. For RARα ChIP qPCR a gene desert on chromosome 6 (Untr6) was used for 
a negative control site (Active Motif Catalog No: 71011). 
 
ChIP Sequencing (Illumina) 
Illumina sequencing libraries were prepared from the ChIP and Input DNAs using standard 
procedures and libraries were sequenced on HiSeq 2500 
 
ChipSeq Analysis 
For each sample the 50bp SE reads in FastQ format from the sequencer were aligned to 
the mouse reference genome (mm10) using Novoalign v2.07.11 
(http://www.novocraft.com). The resulting alignment file was converted to BAM format 
using samtools (http://samtools.sourceforge.net/) and the pcr duplicates were removed 
using picard tools (http://picard.sourceforge.net). Only uniquely mapped reads from each 
!sample were selected for further analysis. Significantly enriched regions from each sample 
were identified with MACS v2.0.10_20131216 (Zhang et al. 2008, Feng J et al. 2011) (with 
q=0.10) using the input sample for background correction. In some instances peaks were 
identified by visual inspection and confirmed by ChIP qPCR. In case of H3K4me1 and 
H3K27me3 samples, “--broad” setting was used to merge nearby enriched regions. For 
visualization purposes, the input signal was subtracted from each ChIP sample and was 
converted into bigWig format using “bedGraphToBigWig“ utility from UCSC tools 
(http://genome.ucsc.edu/util.html). The identified significantly enriched regions were 
annotated to find the associated genes using “FindNeighbouringGenes” utility from USeq 
package (http://useq.sourceforge.net/). Associated genes represent the closest 
transcriptional start site from the centre of the peak. 
 
Microarray data  
Total RNA was extracted from cells lysed in Trizol LS reagent (Life Technologies). RNA 
quality was assessed with an Agilent 2100 Bioanalyzer (Agilent Technologies) and 
quantified with the Nanodrop ND-1000 UV-spectrophotometer (NanoDrop Technologies). 
 
Transcriptome in IFN-γ+ (eYFP+) CD4+ T-cells 
Naïve CD4+ T-cells from dnRara-IFN-γeYFP or littermate control IFN-γeYFP reporter mice 
were cultured under Th1 conditions. On day 7 of culture, following restimulation with PMA 
and ionomycin, eYFP+ cells were sorted and total RNA was extracted for transcriptional 
profiling using Affymetrix Mouse Gene 2.0 ST arrays. Pre-processing and statistical 
analysis of gene expression data were done using Partek Genomics Suite 6.6. CEL files 
!were imported and expression intensities were summarised, normalised and transformed 
using Robust Multiarray Average algorithm. Two additional samples from eYFP+ dnRara or 
wild-type cells sorted without prior restimulation were included in the normalisation. These 
samples were not included in the analysis of differentially expressed genes. P values <0.05 
and fold change in expression ≥ 1.5 or ≤ -1.5 were considered significant. 
 
Transcriptome in Th1 differentiated cells 
Sorted naïve CD4+ T-cells from dnRara or WT mice were polarised under Th1 conditions. 
On day 6 of culture cells were harvested and total RNA was extracted for microarray study 
or ChIP. RNA isolation, microarray and data processing performed by Miltenyi Biotec. 
Transcriptome analysis was performed using Agilent Whole Mouse Genome Oligo 
Microarrays 8X60K in accordance with manufacturer’s protocol. Data analysis was 
performed using R/bioconductor and software packages therein (http://www.R-project.org ; 
http://www.bioconductor.org) or MS-Office Excel (Microsoft Inc.). Background corrected 
intensity values were normalized between arrays using quantile normalization. Quality 
controls include comparison of intensity profiles and a global correlation analysis. 
Differentially expressed genes were identified by statistical group comparisons on 
normalized (background corrected and quantile normalized) log2 transformed fluorescence 
intensities using Student´s t-test (two-tailed, equal variance). Reporters showing a p-value 
≤ 0.05 and a median fold-change in expression ≥ 1.5 or ≤ -1.5 were considered as reliable 
candidates for altered gene expression. In addition, at least two of the replicate samples in 
the group with higher expression were required to have detection p-values ≤ 0.01. 
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CHAPTER 3: RARα orchestrates activation of lineage specific enhancers 
to regulate T helper cell fate 
 
Abstract 
Enhancers are critical for directing cell-type-specific transcriptional programs. 
Differentiation of naïve CD4+ T cells into lineages requires the co-ordinated 
actions of transcription factors and epigenetic modifiers to impart lineage 
stability through stable changes in gene expression. Our findings in Chapter 2 
indicate that RA/RARα can regulate gene expression through the direct 
modulation of enhancer elements at key Th1 and Th17 genes. In Chapter 3, we 
perform a genome wide analysis of RARα regulation of T helper cell enhancers, 
mapping RARα and enhancer activity in CD4+ T cells at different stages of 
differentiation. The data establish that RARα plays a critical role in the 
activation of lineage-specific enhancers. During Th1 and Th17 differentiation, 
RARα is recruited to cell-specific enhancers where it acts, in part, by recruiting 
the coactivator, p300. Thus, RARα plays a broad role in the regulation of T 
helper cell fate and function, providing a molecular basis for the pleiotropic and 






The data presented in Chapter 2 identified a critical role for RARα signaling in 
the maintenance of Th1 cell fate, and identified RARα regulation of key Th1 
genes with reciprocal regulation of the Th17 program. At selected genes, RARα 
was shown to regulate transcription through activation of enhancer regions. 
These findings suggest that enhancer regulation may be the key mechanism by 
which RARα influences gene expression and cell fate.  A recent study identified 
a role for STAT proteins in the regulation of T helper cell enhancers (Vahedi et 
al., 2012).  However, it is not clear whether STATs bind p300 directly, and the 
mechanisms by which coactivators are recruited to specific enhancer sites 
remain incompletely understood. Shortly after publication of Chapter 2, a study 
of oestrogen-receptor-regulated enhancers demonstrated that RARα formed 
part of a complex of transcription factors which are recruited to, and help to 
regulate, oestrogen-receptor dependent enhancers (Liu et al., 2014). A number 
of the coactivators recruited by the protein complex were dependent on RARα. 
These findings hint at a broader role for RARα in the regulation of lineage 
specific enhancers, through recruitment of cofactors which mediate epigenetic 
modifications. 
 
The observed repression of a Th17 program in Th1 cells is consistent 
with the previously reported reciprocal regulation of iTreg and Th17 
differentiation by RARα. However, VAD mice have a near absence of Th17 
cells, suggesting a requirement for RA in Th17 cell differentiation.  Therefore, 
the physiological importance of RA/RARα during Th17 differentiation is 
! 45!
unresolved. The studies in this chapter start to address cell-context dependent 
actions of RARα on Th17 genes. 
 
Here we report a comprehensive analysis of genomic targeting by RARα 
in T helper cell subsets. Our findings identify RARα as a pervasive regulator of 
enhancer regions with p300 recruitment critically dependent on RA signaling. 
Furthermore, RARα is invariably present at super-enhancer regions where its 
presence is required for activation of these enhancers. Remarkably, integration 
of our data with previously published ChIP-seq studies identifies RARα as the 
dominant regulator of enhancer activity. Genome-wide mapping of RARα 
binding and enhancers in T helper cell subsets reveals that RARα targets cell-
type-specific enhancers in Th1 and Th17 cells, providing a mechanistic basis for 
the context dependent effects of RA/RARα on Th17 differentiation. RARα is a 
tantalizing pharmacological target in the treatment of immune mediated 
diseases. A number of selective RARα agonists and antagonists are in 
development. Our findings shed light on the mechanisms by which RARα 
regulates transcriptional pathways and will guide the rational use of RARα 





RARα opposes alternative cell fates in Th1 cells 
In previous chromatin immunoprecipitation followed by sequencing (ChIP-Seq) 
studies (Chapter 2) we identified 1776 RARα binding sites in Th1 cells. 
However, ChIP-seq studies for RARs in other cell types suggest that these 
nuclear receptors are usually bound at several thousand sites across the 
genome (Liu et al., 2014). We therefore performed further ChIP-seq 
experiments resulting in the identification of 16,490 high confidence peaks. 95% 
of previously identified RARα binding sites were validated and good 
reproducibility was observed between biological repeat experiments (r2=0.92) 
(Figure 1). These data sets allowed a comprehensive analysis of the genomic 
targets of RARα in Th1 cells. 
 
Figure 1. Reproducibility of Th1 RARα 
ChIP-seq data Global comparison of RARα 
ChIP-seq experiments between biological 
duplicates demonstrates reproducibility of 
RARα data. The coeffecient of 
determination is indicated in top left hand 
quadrant. 
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33 (70.2%) genes downregulated in dnRara Th1 cells were bound by 
RARα vs. 53 (44.5%) upregulated genes (Figure 2A), confirming our earlier 
findings that RARα plays a dominant role in positive regulation of gene 
expression. We previously identified a number of Th1 defining genes whose 
expression was directly regulated by RARα, as well as RARα-mediated 
antagonism of genes that drive the Th17 lineage (Brown et al., 2015). To 
determine the extent to which RARα regulates the Th1 genome, we performed 
gene set enrichment analysis (GSEA) of transcriptional data from wild-type 
(WT) and dnRara expressing Th1 cells, generated in Chapter 2. As well as 
dysregulation of the Th1-Th17 axis, GSEA revealed enrichment of genes 
preferentially expressed in alternative Th cell lineages, specifically Treg and Tfh 
cells, in dnRara Th1 cells (Figure 2B).  
 
To test for enrichment of RARα binding at T-helper cell specific genes 
we used publicly available transcriptome data for T-helper cell subsets to 
identify a set of T-helper cell specific genes. Th1 genes were enriched for 
RARα binding relative to signature genes associated with other CD4+ T-cell 
subsets. In addition, genes from opposing T-helper cell subsets, in particular 
Treg genes, were enriched for RARα binding relative to a group of genes 
randomly selected across the genome (Figure 2C). The increased expression 
of genes associated with alternative T helper cell lineages in dnRara Th1 cells, 
along with the presence of RARα at these loci, led us to hypothesize that RARα 
may occupy regions targeted by TFs of opposing lineages in order to inhibit TF 
activity at these loci. To test this, we determined the overlap of Foxp3 binding 
sites in Treg cells (Samstein et al., 2012), with RARα binding sites in Th1 cells. 
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We found that 1658 of the binding sites were shared between the two factors, 
representing 64% of Foxp3+ binding sites and 10% RARα binding sites (Figure 
2D). These findings suggest that RARα may reciprocally regulate T helper cell 
developmental pathways by competitively antagonizing the action of 
transcription factors that instruct alternative cell fates. Furthermore, these 
findings lend insight into the increased frequency of Foxp3+ cells observed in 
dnRara mice (Brown et al., 2015; Pino-Lagos et al., 2011). Collectively, these 
data indicate that RARα stabilises the Th1 phenotype through promotion of Th1 
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Figure 2. A global role for RARα  in Th1 lineage stability 
(A) Overlap between the set of genes bound by RARα and the genes up- 
or downregulated in dnRara Th1 cells (fold change 1.5, FDR <0.05) (B) In 
each plot the genes from the array are sorted from left (upregulated in the 
respective comparison) to right (downregulated). The green plot indicates 
the cumulative GSEA score; black bars indicate the location of genes. (C) 
Th1-specific genes show enrichment of RARα binding. Box plots show 
median and quartiles of normalised RARa binding in Th1 cells at Th1-, 
Th2-, Th17- ,Treg-specific genes and 200 randomly selected (Random) 
genes (+/- 20kbp from the TSS). (D) RARα binding sites overlap with 
Foxp3 in Treg cells. 
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RARα is a feature of active enhancer regions 
To further explore how RARα regulates the transcription of genes required for 
Th1 cell function and represses genes from opposing T cell lineages, we 
analysed the distribution of RARα bound regions in Th1 cells. Approximately 
half (51%) of RARα binding sites localised to promoter regions (Figure 3A). To 
determine the transcriptional effects of promoter-bound RARα, we performed 
ChIP-seq for the epigenetic marks H3K4me3 and H3K27me3, histone 
modifications associated with transcriptional activity, and repression 
respectively. These experiments revealed that RARα was largely associated 
with active promoters (Figure 3B). Surprisingly, comparison of H3K4me3 and 
H3K27me3 profiles at RARα bound Th1 promoters in wild-type and dnRara Th1 
cells did not reveal significant differences in deposition of these histone marks 
(Figure 3B).  
! 51!
 
Figure 3. Genome-wide occupancy by RARα in Th1 cells 
(A) Genomic distribution of 16,490 RARα binding sites in Th1 cells at 
promoter, intergenic (>4kbp TSS), and intragenic regions. (B) Normalised 
tag density profiles for H3K4me3 and H3K27me3 at RARα bound 
promoters (-4kbp to +500bp of transcriptional start site [TSS]) in dnRara 
and WT Th1 cells. Plots show the normalized distribution of H3K27me3 or 
H3K4me3 at TSS (+/- 5 kbp)   
A$
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The remaining RARα bound regions were located largely at introns and 
intergenic regions (Figure 3A), suggesting RARα might function at regulatory 
enhancer regions. Comparison of RARα binding with H3K4me1 and p300 
outside of promoter regions (-4kbp to TSS and +500bp) demonstrated that 
RARα was largely associated with genomic regions marked by both H3K4me1 
and p300, putative enhancer elements (Figure  4). Very few RARα bound sites 
were marked with H3K4me1 in the absence of p300, so called ‘permissive’ 
enhancers, indicating that RARα was either recruited to active enhancers or 
played a role in enhancer activation.  
 
Figure 4. RARα binding and epigenetic modifications 
Global mapping identifies concordance between H3K4me1, p300 
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To further evaluate the role of RARα in enhancer elements, we assessed 
the proportion of active enhancers bound by RARα in Th1 cells. Enhancer 
elements were operationally defined as regions enriched for H3K4me1 and 
p300 but depleted of H3K4me3 (Heintzman et al., 2007). Promoter regions 
were excluded from the analysis.  From this analysis, we identified 10,511 
putative enhancer elements. In embryonic stem cells, p300 marks both poised 
and active enhancers, with only the latter marked by H3K27ac (Rada-Iglesias et 
al., 2010). By contrast, in CD4+ Th1 cells, nearly all (91%) enhancers defined by 
the presence of p300 were enriched for H3K27ac (Figure 5). This finding 
indicated that either p300 or H3K27ac was sufficient to distinguish an active 
enhancer in T cells.  
 
 
Figure 5. Defining Th1 enhancers 
Enhancer regions defined by H3K4me1, 
p300 and low levels of H3K4me3 are 
marked by H3K27ac. 
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Strikingly, 3377 (32%) active enhancers were occupied by RARα (Figure 
6A).  This degree of overlap was similar to other Th1 lineage defining 
enhancers that have been implicated in enhancer activation (Figure 6B) 
(Vahedi et al., 2012). RARα binding at putative enhancers was observed at 
many key Th1 genes including Tbx21, Stat4, Ifng and Irf8, Ifngr1, Il12rb2 
(Figure 6C) many of which were previously shown to be downregulated in the 





Figure 6. RARα is a key feature of the Th1 enhancer landscape 
(A) Active enhancers are bound by RARα (B) Overlap of enhancer regions with 
RARα and Th1 lineage defining TFs (C) Chromatin signatures at sites of RARα 
binding. Tracks show RARα, H3K4me1, p300 and H3K27ac occupancy across 
Ifng, Stat4, Il12rb2 and Ifngr1 in Th1 cells 
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Analysis of Th1 enhancers demonstrated that RARα bound enhancers 
were enriched for p300 and H3K27ac relative to enhancers lacking RARα, 
indicating a potential role for RARα in enhancer activity (Figure 7). These data 




Figure 7. RARα binding at enhancers predicts activation 
Compiled tag density profiles for p300 and H3K27ac at RARα bound 
enhancers vs. RARα negative enhancers in Th1 cells. The presence of RARα 
at enhancers is associated with increased p300 and H3K27ac. 
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Enhancer bound RARα regulates transcription 
To determine the effects of RARα at enhancers on gene expression, we 
performed overlap analyses comparing the overlap of DEGs in dnRara Th1 
cells with genes where RARα was bound only at the promoter region or an 
enhancer or both. Consistent with the histone profiles, genes harboring RARα 
solely at promoters did not exhibit significant changes in gene expression 
(Figure 8). In contrast, genes bound by RARα at enhancers were significantly 
enriched among genes positively and negatively regulated by RA/RARα activity 
in Th1 cells. Collectively, our findings reveal that RARα is enriched at Th1 
enhancers and its presence correlates with functional activity.   
 
Figure 8. RARα activity at enhancers regulates gene expression 
Enrichment (blue bars) and significance (red bars) of dnRara differentially 
expressed genes in genes bound by RARα at the promoter (P), enhancer 
(E) or both. Fisher’s exact test.  
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Figure 7 RARa binding at enhancers predicts transcriptional activity$
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RARα signaling is required for Th1 enhancer activation 
In our previous study of selected RARα-bound enhancers, p300 occupancy was 
dependent on RA signaling; this suggested that RA/RARα regulation of 
enhancer functionality may represent a pervasive mechanism by which 
RA/RARα positively regulates gene expression. To explore the functional 
consequences of RARα at active enhancer elements, we utilized p300 ChIP-
seq data from WT and dnRara expressing Th1 cells.  Good reproducibility was 
observed for p300 binding in biological repeat experiments (Figure 9).  
 
 
Figure 9. Reproducibility of p300 ChIP-seq data  
Global comparison of p300 ChIP-seq experiments between biological 
duplicates of WT and dnRara Th1 cells demonstrates reproducibility of p300 
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dnRARα lacks the AF-2 domain, which is the site of interaction with 
p300.  We found that among 3377 RARα bound Th1 enhancers, 20% (698) are 
dependent on RA signaling with a dramatic inhibition of enhancer activity as 
evidenced by loss of p300 and H3K27ac (Figure 10A and 10B).  Only 30 RARα 
enhancer regions showed increased p300 in the absence of RA signaling. 
Although H3K4me3 is depleted at enhancers relative to promoters, its presence 
is associated with enhancer activity (Wang et al., 2008). We also observed 
reductions in H3K4me3 at RARα bound enhancers in dnRara Th1 cells (Figure 
10C), indicating reduced transcription from these sites. Intensity of H3K4me1 at 
the p300 peak summit was similar between dnRara and WT Th1 cells; although 
the breadth of the peak was reduced in the absence of RA signaling, the 
unchanged peak intensity suggests that RARα activity is not required for 
deposition of H3K4me1 (Figure 10D). Loss of RA signaling did not result in 
increased levels of the repressive mark, indicating that regulation of enhancer 
activity by RA is through p300 recruitment, not removal of H3K27me3 (Figure 
10C). Thus, RARα is associated with enhancers where its ability to recruit 
coactivators is required for enhancer activation.  
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 Figure 10. RARα signaling is critical for active enhancers in Th1 cells 
Tag density profiles for (A) p300, (B) H3K27ac, (C) H3K27me3 and (D) 
H3K4me1 at RARα bound enhancer regions in dnRara and WT Th1 cells 
demonstrate that RARα bound enhancers are dependent on RA signaling for 
p300 recruitment and functional activity. Removal of H3K27me3 from 
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RARα is enriched at lineage defining super-enhancers 
Super-enhancers (SEs) have been suggested to be the key determinants of 
lineage identity. Given the essential role for RARα in maintaining Th1 cell fate, 
we assessed the proportion of Th1 SEs with RARα occupancy using publicly 
available data for SE regions in T helper cell subsets (Vahedi et al., 2015). 
Remarkably, we found that RARα binding was present at 85% of Th1 SE 
regions (Figure 11A), with a similar level of enrichment at Th1 lineage-specific 
SEs (77%) (Figure 11B). The observed increased frequency of RARα 
occupancy at SEs vs typical enhancers may have reflected the increased size 
of SE regions: the genomic regions of SEs are approximately an order of 
magnitude greater than that of a typical enhancer element (Whyte et al., 2013). 
To assess the specificity of this enrichment, we evaluated the occupancy of 
RARα at a comparable region of the genome. For this purpose we examined, 
within Th1 cells, the genomic elements which have super-enhancer structure 
specifically in Th2 cells but not Th1 cells (Vahedi et al., 2015).  We did not 
observe an increase in RARα occupancy at these regions (Figure 11C), 
confirming the specificity of RARα binding to Th1 SEs. To determine the 
contribution of RARα in generating super-enhancer structures, we compared 
p300 profiles in WT and dnRara Th1 cells. Deficiency in RARα signaling 
resulted in a significant reduction in p300 marks at SEs bound by RARα but not 
RARα depleted super-enhancers (Figure 11D), arguing for a direct role of 
RARα in generating super-enhancers.  Collectively, these data indicate that 
RARα signaling is enriched at cell-type specific SEs and is essential for 





Figure 11. RARα is enriched at Th1-specific super-enhancers and is 
critical for the generation super-enhancer architecture. 
Piecharts showing (A) the proportion of Th1 super-enhancers (SEs) bound 
by RARα in Th1 cells, (B) the proportion of Th1-specific SEs bound by RARα 
in Th1 cells or (C) the proportion of regions with SE architecture in Th2 cells 
bound by RARα in Th1 cells. SE regions are defined in Vahedi et al. 2014. 
(D) Tag density plots showing p300 binding patterns across Th1 SE regions 
in dnRara and WT Th1 cells at RARα bound Th1 SEs (left panel) or RARα 
negative Th1 SEs (right panel). 
 
  
SE occupied by RARα in Th1
SE without RARα binding in Th1SE occupied by RARα 







RARα bound Th1 SE region     RARα negative Th1 SE region 
D$









Average Profiles around the Center of Sites

























Average Profiles around the Center of Sites
























































SE occupied by RARα in Th1






RARα is the dominant chromatin modifier at enhancer elements 
In a recent study, Th1 lineage-defining STAT proteins, STAT1 and STAT4, were 
shown to associate with enhancers and regulate enhancer activity with a minor 
role for T-bet. Given that these TFs show similar degrees of overlap with 
enhancer regions, we wondered whether these factors were binding at the 
same enhancers and regulating enhancer activity in a co-operative manner. To 
better understand the relationship between RARα and other Th1 associated 
transcription factors, we evaluated the co-occupancy of RARα and lineage 
specific TFs using publicly available ChIP-seq data sets to compare the binding 
profiles of T-bet, STAT1 and STAT4 in Th1 cells at enhancers. There was 
extensive overlap between individual RARα binding sites and those of key Th1 
cell regulators (Figure 12A), with co-occupancy noted at enhancers of key Th1 





Figure 12. Co-localization of RARα and key Th1 transcription factors at 
active enhancers in Th1 cells 
(A) The numbers of peaks identified for RARα bound enhancers that co-
localize with T-bet, STAT4 and STAT1 bound enhancers in Th1 cells (left 
panel). Numbers of peaks identified for overlapping proteins as a percentage 
of the total RARα-bound enhancer peaks identified (right panel). (B) Co-
occupancy of RARα, p300, T-bet, STAT1 and STAT4 at enhancers of Th1-































































To determine the relative contribution of each of these factors on 
recruitment of p300 to enhancers, we compared p300 intensity at enhancers 
with different patterns of transcription factor occupancy. Similar levels of p300 
enrichment were observed at enhancers bound solely by RARα, T-bet, STAT4 
or STAT1 (Figure 13), indicating that each of these factors can play a role in 
p300 recruitment. Interestingly, RARα had a far greater effect on H3K27ac 
deposition at enhancers than the lineage associated transcription factors, 
despite equivalent levels of p300, indicating that RARα may also regulate 
histone acetylation through recruitment of other co-activators with histone 
acetyltransferase activity, such as CBP.  H3K27ac correlates with 
transcriptional activity at enhancer regions, suggesting that the functional 
strength of RARα bound enhancers is greater than enhancers occupied solely 
by T-bet, STAT4 or STAT1. An increase in p300 and H3K27ac intensity was 
observed when RARα was co-bound with any other of the lineage determining 
transcription factors indicating coordinate activation of enhancers by signal 
dependent and lineage specific transcription factors (Figure 13). 
! 66!
 
Figure 13. Regulation of p300 binding by RARα and key Th1 
transcription factors. 
Compiled tag density profiles for p300 (left panel) and H3K27ac (right panel) 
at Th1 enhancers uniquely bound by RARα, STAT1, STAT4 or T-bet; or 
RARα in combination with one of STAT1, STAT4 or T-bet. RARα has 
comparable effects on p300 recruitment with other Th1 lineage-determining 
transcription factors (LDTFs) but greater effects on H3K27ac. Combinatorial 
effects of RARα and Th1 LDTFs on p300 recruitment and H3K27ac are 
observed.  
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To determine the relative contribution of these factors to p300 
recruitment, we performed a linear regression analysis to predict p300 intensity 
from the presence of these transcription factors. As expected, all four 
transcription factors had statistically significant predictive ability (Figure 14). 
Strikingly, the presence of RARα was the greatest predictor of p300 intensity. 
Intriguingly, the analysis revealed a synergistic relationship between T-bet and 
RARα on p300 recruitment, which was not observed for any other pairwise 
combinations of transcription factors. Collectively, these data indicate that an 
RA signal at RARα bound enhancers is an additional mechanism by which 
enhancers can become activated and suggest that RARα is the dominant 
regulator of p300 at enhancers. 
 
 
Figure 14. RARα is the dominant regulator of p300 recruitment at 
Th1 enhancers 
A multiple linear regression analysis was calculated to determine the 
predictive effects of RARα and Th1 transcription factors on p300 
binding at Th1 enhancers. Coefficient reflects the size of the effect. 
The presence of RARα and T-bet together had a greater effect on 
p300 intensity than would be expected from the individual effects of 
these factors.   **** p <0.0001  
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RARα is recruited to cell-type specific enhancers during differentiation 
Enhancers are cell-type specific and developmental stage specific. Yet it has 
also been proposed that RARα is constitutively bound to its targets and in the 
absence of retinoids, co-repressors are recruited to the receptor to prevent 
transcription. To determine whether RARα was bound at permissive enhancers 
in naïve T cells that become active during Th1 differentiation, or whether RARα 
is recruited to enhancers, we compared binding of RARα in naïve CD4+ T cells, 
Th1 cells and Th17 cells. Comparison with Th17 cells allowed assessment of 
RARα binding in response to TCR activation, independent of the cytokine 
milieu. p300 ChIP-seq in Th17 cells was also performed to identify Th17 cell 
enhancers. We identified 13,014 statistically significant RARα peaks in naïve 
CD4+ T cells and 12,426 in Th17 cells with good reproducibility between 
biological repeat experiments (r2 = 0.86) (Figure 15).   
 
Figure 15. Reproducibility of RARα 
ChIP-seq data in Th17 cells  
Global comparison of RARα ChIP-seq 
experiments between biological duplicates 
demonstrates reproducibility of RARα data. 
The coeffecient of determination is 
indicated in top left hand quadrant. 
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Of these, 5552 RARα peaks (33% of Th1 and 45% of Th17) were common to 
naïve, Th1 and Th17 cells (Figure 16). We observed a shift in RARα binding 
during CD4+ T cell differentiation with 6217 peaks exclusively bound in Th1 
cells, representing 37% of RARα bound Th1 sites, and 3,728 novel peaks in 
Th17 cells (30% of total Th17 peaks) (Figure 16). Only 1965 (16%) 
differentiation-induced RARα bound elements were shared between Th1 and 
Th17 cells indicating that distinct environmental cues direct lineage specific 
RARα binding.  
 
 
Figure  16. RARα binds to cell-specific regions during naïve 
CD4+ T-cell differentiation 
Heatmaps, based on ChIP-seq data, showing RARα binding in 
naïve, Th1 and Th17 cells. The plot in each column represents 
the pattern of RARα binding centred on the RARα-bound sites 
in each cell type.    
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Comparison of cell-specific RARα binding peaks revealed that RARα binding in 
response to differentiation was largely directed to regulatory regions (Figure 
17), consistent with cell-type-specific actions of RARα. 3071 (49%) of Th1 
specific peaks and 769 (21%) of Th17 specific peaks overlap Th1 and Th17 
enhancers respectively. For this analysis, putative enhancers were defined as 
p300 binding peaks outside of promoters. 
 
 
Figure 17. Cell-type specific binding peaks are enriched at regulatory 
regions 
Pie chart of the genome-wide distribution of RARα peaks in naïve and Th17 
cells (upper panel), and cell-type specific peaks in Th1 and Th17 cells 
(lower panel), based on Ref-seq. Cell-type specific peaks are enriched at 
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Analysis of T helper cell signature genes demonstrated lineage specific 
patterns of RARα binding with overlap of RARα at the relevant lineage 
enhancer (Figure 18A).  Genes selectively expressed in Th1 cells were 
significantly enriched in genes harbouring a Th1-specific RARα binding site 
(Figure 18B). Similarly, analysis of genes containing Th17-specific RARα 
bound loci revealed significant overlap with a literature-curated set of Th17 
relevant genes (Figure 18B). Collectively, these data show that in response to 
cytokine-directed differentiation, RARα selectively binds to elements within 
genes preferentially expressed in the relevant lineage. This indicates that RARα 
regulation of lineage specific genes occurs in response to extrinsic cues that 
drive differentiation of naïve CD4+ T cells towards a specific lineage.  
! 72!
 
Figure 18. RARα binds overlapping and distinct T helper cell enhancers 
and  lineage-defining genes 
(A) Gene track represents RARα binding in WT naïve, Th1 and Th17 cells in 
Ifng, Irf8 and Stat4 locus. (B) Overlap of signature Th1 (left panel) and Th17 
(right panel) genes harbouring cell-type-specific RARα peaks with T helper 
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Functional analysis of lineage specific RARα bound regions 
To gain further insight into the lineage specific pathways targeted by RARα, 
likely to be relevant to Th1 function, we performed pathway analyses on the 
genes associated with unique RARα binding sites in Th1 cells. For this, we 
used GO and KEGG databases as well as MSigDB (Broad Institute).  As 
expected, genes involved in cytokine signaling and lineage specification were 
highly enriched for genes containing Th1-specific RARα peaks. Strikingly, 
genes associated with regulation of metabolic processes, including OXPHOS 
and mTOR signaling, were significantly enriched in genes harbouring Th1-
specific RARα-binding sites (Figure 19). It is increasingly appreciated that 
these metabolic pathways are critical for successful effector T-cell responses. A 
number of signaling pathways including TCR, cytokine and complement 
signaling have been shown to regulate the expression of key metabolic genes. 
As well as regulation of lineage-defining transcription factors, cytokines and 
their receptors, it now appears that RA/RARα also regulates metabolic 
pathways. Intermediaries in metabolic pathways are key cofactors required for 
epigenetic modifications. In addition, pathway analysis identified enrichment of 
genes involved in H3K9 demethylation. Thus RA/RARα may regulate 




Figure 19. Functional analysis of Th1-specific RARα binding regions 
Pathway analysis of genes associated with Th1-specific RARα peaks 
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RA/RARα regulates Th17 differentiation 
The finding of unique binding sites for RARα in Th17 cells at Th17 signature 
genes was also of interest, as the role of RA in these cells has been one of 
continuing controversy. Our previous study (Chapter 2) along with a number of 
published studies of RA and Th17 cells suggest an inhibitory role for RA/RARα 
on the Th17 program. To determine the functional significance of RARα binding 
at these loci we polarized dnRara naïve CD4+ cells under Th17 conditions and 
analyzed the expression of IL-17 and RORγt. Surprisingly, in contrast to the 
repression of the Th17 phenotype by RARα in Th1 cells, we did not observe 
enhanced Th17 responses in Th17-polarised dnRara CD4+ T cells. Preliminary 
data showed a loss of Th17 phenotype at day 6 of culture, indicating a similar 
requirement for RA in maintenance of Th17 cell fate (Figure 20A). A third of 
Th17 enhancers, defined as p300 peaks outside of promoters, were bound by 
RARα in WT Th17 cells at day 3 of differentiation (Figure 20B). At day 5, a 
similar number (2276) of p300 binding sites were occupied by RARα reflecting 
17% of total enhancers at this timepoint (Figure 20B). Similar to our findings in 
Th1 cells, RARα was associated with increased p300 intensity at enhancer 
regions (Figure 20C). Transcriptional profiling is required to confirm the 
significance of RARα bound Th17 enhancers, but preliminary results suggest 
an important role for RARα in Th17 cell fate. Collectively, these findings show 
that RARα binds to overlapping and distinct genomic regions in T helper cell 
subsets, and suggest that RARα regulates T helper cell fate by targeting 




Figure 20. RARα regulates Th17 differentiation 
(A) Naïve CD4+ T cells from dnRara or WT mice were cultured under Th17 
conditions. Intracellular expression of IL17-A and RORγt expression was 
analysed at the indicated timepoints following stimulation with PMA and 
ionomycin. Numbers in quadrants represent percent cells in each. Grey 
histograms indicate isotype control antibody. (B) Piecharts representing the 
proportion of Th17 enhancers that are bound by RARα in Th17 cells at day 3 or 
5 of culture. Regions of p300 binding outside of promoters were considered to 
be enhancer elements. (C) Tag density profiles of p300 binding in dnRara or 
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Lineage determining transcription factors might recruit RARα for 
enhancer activation 
RARα is broadly expressed by T helper cell subsets as well as non-T-cell 
lineages. However, the data above demonstrate cell-type-specific binding of 
RARα. The lineage specificity of differentiation-induced RARα binding in Th1 
and Th17 cells suggested that cell context dependent effects of RARα on gene 
expression resulted from recruitment of RARα to lineage specific genes in 
response to extrinsic cues or intrinsic factors that are induced during lineage 
specification. A recent study identified RARα as part of a transcription factor 
complex that was bound in trans at oestrogen dependent enhancers. We 
hypothesized that RARα may play an analogous role in Th1 cells, where it may 
be recruited to cell-specific enhancer by other Th1 defining transcription factors. 
In order to identify potential pioneer factors or co-factors that may facilitate 
RARα binding, we studied the DNA sequences for regions bound by RARα 
specifically in Th1 cells, comparing enhancer with non-enhancer regions. 
Transcription factors with motif enrichment in Th1-specific RARα-bound 
enhancers included the ‘master regulator’ T-bet as well as Ets1, Runx and an 
activator protein 1 (AP-1) which may represent binding of a number of factors 
including BATF, Fos or Jun (Figure 21). 
 
How RARα is selectively recruited to novel enhancers in Th1 and Th17 
cells remains unclear. Two possible models exist: either pioneer factors at Th1 
enhancers alter the chromatin accessibility of these regions and allow binding of 
RARα, or, lineage-specific factors bound at Th1 enhancer regions recruit RARα 
through their trans activation domains. Further analysis of the cell-type-specific 
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RARα bound enhancers are required to resolve these possibilities. Given the 
overlap of T-bet and RARα binding at enhancers (>40%) and the synergistic 
effect of RARα and T-bet on p300 recruitment, T-bet may play a key role in 




Figure 21. Identification of putative pioneer factors and 
RARα cofactors at Th1 enhancers  
Examples of motifs within Th1-specific RARα-bound 
enhancers for transcription factors which may serve as 


















The molecular mechanisms responsible for orchestrating genome wide 
transcriptional responses, and epigenetic modifications during T helper cell 
differentiation, are not fully understood. Enhancers play a key role in directing 
cell fate through the regulation of lineage specifying genes, and there has been 
much interest in identifying the factors that link extracellular signals with 
changes at the chromatin level. The studies reported in Chapter 2 suggested 
that RA signaling in differentiating Th1 cells is able to regulate enhancer 
functionality.  Here we set out to examine the extent to which RA/RARα 
regulates the Th1 cistrome. Two interesting conclusions emerge. One is that the 
RA/RARα axis regulates Th1 cell phenotype through multiple transcriptional 
pathways, not limited to a few classical transcription factors and cytokines.  The 
other conclusion is that, although multiple transcription factors regulate the 
transition of Th1 enhancers to an active state, RA is dominant. Our data 
establish the RA/RARα signaling axis as a global regulator of the Th1 program.  
 
Furthermore, the role of RA/RARα extends beyond Th1 cells. Mapping of 
RARα binding in naïve and differentiated T helper cells suggest that distinct 
transcriptional networks in differentiating CD4+ T cells facilitate binding of RARα 
to subset specific enhancers. Comparison of RARα regulation of enhancers at 
different stages of differentiation and across CD4+ T cell subsets identified 
lineage specific actions of RARα at genes that control cell identity.  These 
studies reveal a molecular basis for a broader role for RARα in the regulation of 
cell fate.  
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RARα occupancy is a feature of functional enhancers in Th1 cells 
Our findings suggest that the presence of RARα at enhancers predicts 
enhancer activation and that RARα signaling is critical for enhancer 
functionality. Signaling through RARα allows binding of p300 to the AF-2 
activating domain of the RAR. Th1 cells expressing dnRARα that lacks the AF-2 
domain had reduced levels of p300 and H3K27ac at RARα-bound enhancers, 
indicating a direct role for RARα in p300 recruitment. RARα may have other 
roles beyond p300 recruitment. Although similar levels of p300 occupancy were 
observed between RARα and STAT bound enhancers, RARα bound enhancers 
had far greater levels of H3K27ac. Although binding does not necessarily imply 
transcriptional changes, H3K27ac is predictive of enhancer functionality. The 
p300-independent effect of RARα may be because RARα interacts with a 
number of co-activators, including the histone acetyltransferase CBP (Kamei, 
1996). In addition to recruitment of HATs, another mechanism by which RARα 
may regulate enhancers is illustrated by a recent report of RAR dependent 
recruitment of the DNA-dependent protein kinase, (DNA-PKc) which is required 
for ligand-induced activation of enhancer transcription (Liu et al., 2014).  
 
Even more striking than the proportion of enhancers binding RARα was 
its highly enriched binding at super-enhancer regions. 86% of these exhibited 
RARα binding. Furthermore, we can infer a direct role for RARα in the 
regulation of super-enhancer activity from the finding that loss of p300 binding 
in dnRara Th1 cells was only observed at RARα-bound super-enhancers. 
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The experiments in this chapter show that RARα signaling serves as a 
mechanism to promote recruitment of coactivators that increase enhancer 
activation and transcription.   
 
Retinoic acid is a global regulator of T helper cell stability  
Our findings build on previous findings in Chapter 2 that RARα reinforces Th1 
stability by repressing genes associated with Th17 lineage. We now show that 
RARα additionally contributes to Th1 stability by directly controlling the 
expression of signature genes of other T helper cell lineages, including Tfh and 
Treg cells. Specifically, we have shown that in Th1 cells, RARα is bound at a 
significant proportion of the regions occupied by Foxp3 in Tregs. It will be 
important to identify the in vivo environments in which RA signaling regulates 
the conversion of Th1 cells to Treg or Tfh cells. A recent study showed that a 
single naïve T cell clone can give rise to a variety of different T helper cell types 
(Becattini et al., 2015). One possibility is that gradients in RA concentration, 
generated as a consequence of the distance of a proliferating cell from the 
source of RA, determines whether a differentiating cell maintains its original 
specification or adopts an alternative cell fate. Clearly flexibility in the CD4+ T 
cell response can be advantageous. For instance a Th1 to Treg switch would 
allow the development of Treg cells with features of Th1 cells. Indeed, the 
ability of Treg cells to adopt features of effector T cells is critical for these to 
cells to control inflammation mediated by those cells in the periphery (Koch et 
al., 2009).   
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In addition to regulating Th1 plasticity, analysis of RARα binding in Th17 cells 
identified RA regulation of Th1 associated genes, such as Tbx21 and Il12rb2, 
suggesting that RA signaling might be required for the plasticity of Th17 cells in 
response to a Th1-polarising stimulus. Such plasticity has been observed in 
vitro and in vivo and is associated with autoimmune disease pathogenesis 
(Basu et al., 2013). 
 
Distinct mechanisms of gene regulation by RARα 
The ability of RARα to repress alternative cell fates highlights the importance of 
gene repression by RA/RARα. A number of genes that were bound by RARα 
were transcriptionally repressed. Whilst our data provides a clear mechanism by 
which RA/RARα positively regulates gene expression, it remains unclear how 
RARα represses genes that instruct alternative cell fates to enforce lineage 
stability. RA signaling through RARα can also induce binding of co-repressors 
(e.g. RIP-140) to the AF-2 domain. It is unclear what factors determine binding 
of a coactivator complex vs. a corepressor complex to RARα. Differential 
effects of ligand-dependent receptors on transcription has previously been 
demonstrated (Diamond et al., 1990). Further analysis of the binding sites that 
mediate ligand-dependent inhibition of genes and those that mediate positive 
transcription by RARα may reveal distinct binding partners that determine the 
differential effects of RARα. An unexpected observation was that RARα binding 
at promoters has no effect on gene transcription in the absence of RARα 
binding at its presumed enhancer. It is unclear, in this case, what role RARα 
plays at the promoter. We speculate that RARα may act as a signal sensing 
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scaffold that regulates chromatin interactions between promoter and enhancer. 
Thus, promoter bound RARα only becomes relevant once its cognate enhancer 
is activated. 
 
Interplay of RARα and Th1 lineage defining transcription factors 
T-bet, STAT4 and STAT1 have also been shown to drive active enhancers in 
Th1 cells (Vahedi et al., 2012). We identified a high degree of overlap between 
the sites occupied by RARα and lineage-determining transcription factors 
(LDTFs) in Th1 cells. Previous studies have focused on identifying individual 
TFs that may account for enhancer activation. However, it is clear that 
enhancers are platforms for multiple TFs and these factors contribute to 
enhancer activation, often in a cooperative manner. Enhancers may appear to 
be dependent on one transcription factor, as a result of the hierarchy in TF 
binding, whereby Factor A recruits B which in turn recruits C. In this model, loss 
of Factor A would prevent enhancer activation but A, B and C are all required 
for a fully functioning enhancer. A is necessary but not sufficient. Whilst STAT 
proteins may be critical for enhancer activation, it is possible that they operate 
through RARα.  
Importantly, our analysis identified independent effects of RARα on p300 
recruitment, suggesting that RARα is an additional layer of the machinery 
required for the activation of Th1 enhancers. The combinatorial effects of RARα 
along with T-bet, STAT1 and STAT4 on p300 binding at enhancers suggest a 
complex layer of regulation allowing enhancers to integrate extracellular cues 
received from both cytokines and RA. The different combinatorial patterns of 
transcription factor binding at active enhancers suggest that some enhancers 
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may require multiple signals to become fully active. Strikingly, amongst key Th1 
cell regulators, RARα appeared to have the greatest effect on p300 recruitment. 
   
An intriguing finding that warrants further investigation is the synergistic 
relationship of RARα and T-bet on p300 recruitment.  Possibly, allosteric 
interactions between T-bet and RARα may facilitate binding of p300 to the 
respective proteins. Thus, in addition to regulating the expression of Th1 
LDTFs, as demonstrated in Chapter 2, it appears that RARα acts post-
translationally in co-operation with these transcription factors to generate active 
enhancers. 
 
RARα is selectively recruited to lineage specific enhancers 
RARα regulation of naïve CD4+ T cell fate is not restricted to Th1 cells. 
Comparison of enhancers across naïve, Th1 and Th17 cells allows a temporal 
analysis of cell-specific enhancers. Our data indicate that RARα is selectively 
recruited to lineage-specific enhancers, suggesting that LDTFs may guide 
RARα targets. This selective recruitment provides a mechanistic basis for the 
pleotropic effects of RA on T-cell fate.  RARα occupancy overlapped with 
combinations of Th1 defining transcription factors rather than one particular 
transcription factor. Thus, it remains unclear how RARα is recruited to these 
sites, and whether indeed there is a single, responsible factor. Motif analysis of 
the Th1 lineage-specific RARα bound enhancers did not reveal a specific co-
factor, but indicated the presence of a number of candidate pioneer factors, e.g. 
AP-1 and RUNX. Further studies are required to confirm co-occupancy. It is 
unclear whether these factors recruit RARα in order to activate enhancers, or 
! 85!
RARα modulates chromatin in order to allow these TFs to bind.  Nearly all 
RARα bound sites were occupied by p300 with very few RARα bound 
enhancers marked solely by H3K4me1. In addition, RARα was not required for 
H3K4me1 deposition at enhancers. This suggests that RARα is recruited to 
permissive enhancers downstream of pioneer factors. Dynamic ChIP-seq 
studies for these transcription factors during Th1 differentiation will allow greater 
temporal resolution of the order of binding events at Th1 enhancers, and shed 
light on the step-wise processes that generate active enhancers. 
 
It has been suggested that RARα forms part of a multi-protein complex 
that regulates enhancer activity through recruitment of co-regulators (Bush et 
al., 2003; Liu et al., 2014). Our data support such a model, providing evidence 
that p300 recruitment is critically dependent on the presence and activation of 
RARα at enhancers.  
 
RA/RARα regulation of Th17 enhancers 
The data in chapter 3 provide a mechanistic basis for the paradoxical effects of 
RA on Th17 differentiation, demonstrating cell-context dependent actions of 
RARα at Th17 related genes. During both Th1 and iTreg differentiation, 
RA/RARα signaling has been shown to repress Th17 lineage development 
(Brown et al., 2015; Mucida et al., 2007). However, studies with vitamin A 
deficient mice have suggested that RA is also required for Th17 generation at 
mucosal sites both in steady state and in response to inflammation (Hall et al., 
2011; Uematsu et al., 2008). These studies were performed in vitamin A 
deficient mice and it was not clear whether there was a cell intrinsic role for 
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RA/RARα in the generation of Th17 responses. Comparison of RARα binding in 
differentiating Th1 vs. Th17 cells showed overlapping but distinct targets and 
initial results suggest that RARα signaling is required for stable RORγt and IL-
17A expression in Th17 cells. The cell context dependent effects of RARα may 
be mediated in part through expression of distinct co-factors amongst CD4+ T 
cells.  Further analysis of the cell-specific RARα bound regions will shed light 
on potential lineage-specific co-factors. 
 
Transcription factor binding does not necessarily equate with 
transcriptional changes and further studies are required to confirm the in vivo 
relevance of RARα regulation of Th17 loci and identify the circumstances in 
which RA regulates Th17 responses. Th17 cells represent a heterogeneous 
lineage and these cells display considerable early and late phase plasticity. 
RARα binding at the Tbx21 and Ifng loci in both Th1 and Th17 cells suggests 
that RA may regulate the conversion of Th17 cells to IFN-γ+IL-17+ cells. 
Transcriptional profiling of dnRara Th17 cells along with studies of their 
stability/plasticity are required to dissect out the role of RA in the regulation of 
Th17 differentiation.  
 
Translational significance 
There are at least two ways in which an understanding of the spatiotemporal, 
cell-context specific actions of RARα is critical for translation of these findings 
into clinical practice. Firstly, they may help explain a paradoxical observation 
that has arisen from the use of Vitamin A supplementation in areas where 
vitamin A deficiency is endemic. Although hailed as a success, meta-analysis of 
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vitamin A supplementation in children has identified sub-groups in whom routine 
supplementation is associated with increased morbidity and mortality. We can 
now speculate that, since RA/RARα may enhance effector immune responses, 
the administration of RA during such a response (e.g. an acute infection) may 
be inadvertently harmful. Secondly, the RA/RARα signaling axis is a therapeutic 
target for a number of selective RARα agonists in development. These have a 
potential role both in autoimmune disease, in which dysregulated Th1/Th17 
responses are observed, and for enhancing Th1 effector responses, e.g. as an 
adjuvant in tumour immunotherapy. However, it is apparent from studies in this 
chapter that the choice and use of agonist will depend on whether the desired 
response is repression or activation, and requires p300 recruitment, ligand 
blockade, or as yet unidentified protein interactions. 
 
In summary, our results identify global effects of RA/RARα on epigenetic 
landscape in T helper cells and demonstrate cell context-dependent effects of 







CHAPTER 4: CONCLUSION 
 
RARα maintains Th1 lineage commitment in vitro and in vivo 
My investigations have redefined the role of RARα in T helper cell specification.  
Prior to these studies, RARα had been shown to enhance iTreg generation in 
vitro, and a role for RARα in Th1 responses in vivo had been suggested. But 
the mechanistic basis for the cell-specific actions of RA in the regulation of T-
cell fate has remained elusive. Initial reports concluded that RARα played a role 
in T cell activation. However, these studies were performed in RARα–/– mice 
which may not be an appropriate genetic model for loss of RA signaling.  
Although RARα is known to be a signal-dependent transcription factor, no 
previous study had explored the genome wide regulation of CD4+ T-cell 
programs by RARα.  The studies presented in chapter 2 show that RA signaling 
through RARα is critical for maintenance of Th1 commitment. The ChIP-
sequencing studies in both chapters 2 and 3 show that RARα positively 
regulates the transcription of key Th1 factors to reinforce lineage stability, whilst 
antagonizing alternative T helper cell programs.   
 
The requirement for RA signaling for late phase Th1 commitment, but not 
lineage specification, may be explained by the finding that RARα regulates 
expression of Th1 lineage defining transcription factors by activation of cis-
regulatory enhancer regions.  Enhancer regions are activated during the course 
of T-helper cell differentiation (Hawkins et al., 2013), and it has been suggested 
that the role of enhancers is to sustain rather than initiate gene transcription. 
Recruitment of RARα to enhancers may be dependent on transcription factors 
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whose expression is upregulated during the course of Th1 differentiation.  The 
temporal effects of RA may explain findings from previous in vitro studies in 
which bi-phasic effects of RA were noted during Th1 polarization.  Animal 
models which allow temporal control of RA signaling will be invaluable for 
dissecting out the role of RA in early vs. late phase differentiation.  
 
The discovery that Th1 cells require RA signaling to maintain their 
phenotype upon reactivation may have implications for therapeutic strategies in 
autoimmune disease where a dysregulated Th1-Th17 axis plays a role in 
disease pathogenesis. Our data support a model whereby therapeutic 
administration of RA would drive differentiation of Th1-Th17 cells to terminally 
differentiated Th1 cells with reduced survival in contrast to their Th17 
counterparts (Muranski et al., 2011). In support of this therapeutic strategy, a 
recent study showed that RA treatment of CD4+ T-cells from patients with 
ankylosing spondylitis resulted in a reduced frequency of IL-17+ cells and a 
concomitant increase in IFN-γ+ cells (Bidad et al., 2013). 
 
Novel players in the regulation of Th1 stability 
Early studies of Th1 regulators identified transcription factors that were both 
necessary and sufficient for the Th1 phenotype.  Advances in transcriptional 
profiling have expanded the network of transcription factors expressed by 
different T helper cell subsets (Ciofani et al., 2012).  It is increasingly evident 
that commitment and maintenance of a particular T-helper cell phenotype is 
dependent on the interplay between numerous transcription factors.  Analysis of 
RARα-bound loci in Th1 cells in parallel with RA dependent gene expression 
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profiling uncovered novel candidates.  Our results in Chapter 2 demonstrated 
that IRF8 forms part of the transcriptional network in Th1 cells and is critically 
dependent on RA signaling.  Although previously shown to play a role in 
suppressing IL-17 in Th17 cells, a role for IRF8 in Th1 cells had not been 
established.  Shortly after publication of this work, another group published a 
study corroborating our findings (Lee et al., 2015), demonstrating selective 
expression of IRF8 in Th1 and Tr1 cells and a role for IRF8 in the expression of 
Th1 associated genes in Treg cells.   
 
Functional analysis of Th1 specific RARα bound regions highlighted a 
number of key transcriptional pathways that may be dependent on RA 
signaling, including metabolic pathways. RA-mediated regulation of these 
pathways warrants further investigation. 
 
RA/RARα confers stability to T helper cell commitment  
RA synthesis occurs at sites of T-cell priming in response to a diverse array of 
stimuli.  In the steady state, constitutive expression of RALDH isoforms by 
APCs and stromal cells is observed at barrier sites including the skin, lung and 
gut.  It is perhaps not surprising, given the importance of RA in regulating T cell 
fate, that steady state production of RA occurs at mucosal sites where T cells 
are continuously differentiating in response to commensals and other innocuous 
antigens.  In keeping with this, microbial products have been shown to induce 
the expression of raldh isoforms (Singh et al., 2014). Outside of these sites, RA 
synthesis can be induced by inflammation as demonstrated in a number of in 
vivo models (Allie et al., 2013; Hall et al., 2011; Pino-Lagos et al., 2011).   Our 
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studies have now shown the fundamental importance of an RA signal during T 
cell priming.  The data demonstrated that RA signals during T helper cell 
differentiation are required for enhancer activation to reinforce initial lineage 
specification.  In this way RARα, a nuclear receptor, bridges the extracellular 
environment with transcriptional and epigenetic machinery.  Our studies have 
focused on regulation of Th1 enhancers.  However, the data presented in 
Chapter 3 suggest a pervasive role for RA/RARα in the generation of active 
enhancers in alternative T helper cell subsets. Multiple signals are required to 
activate a T helper cell differentiation program. It now appears that RA signaling 
is also required to stabilize initial lineage specification through epigenetic 
modifications. We propose that, in addition to TCR engagement, co-stimulatory 
signal and cytokine receptor signal, an RA/RARα signal is a further checkpoint 
that acts to link the extracellular environment to transcriptional changes by 
licensing the recruitment of p300 and other factors which regulate H3K27 
acetylation. A continuous requirement for RA signaling provides flexibility to T 
helper cells, allowing RA gradients to regulate T cell plasticity in response to 
changes in the extracellular milieu. 
 
Dissecting the multi-step process required for generation of cell-specific 
enhancers   
Given the fundamental importance of enhancer regions in determining cell fate, 
the mechanisms responsible for enhancer activation and function have been 
the focus of intense investigation.  Despite advances in our ability to globally 
map enhancer regions, mechanistic understanding of the processes required to 
confer epigenetic changes remains elusive.  Studies in models of cellular 
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differentiation indicate that there is a precise and hierarchical temporal order of 
transcription factor binding and co-factor recruitment.  This process is initiated 
by the binding of pioneer transcription factors.  Chromatin accessibility then 
allows binding of lineage-specific factors to these regions.  Our findings 
integrate RA signals into this multi-step process.  RA is not required for initiation 
of enhancers suggesting that alternative pioneer factors are required before 
RARα can activate enhancers through the recruitment of p300.  Despite the 
expression of RARα by naïve T cells, effects of RA on T-cell polarity are only 
observed following T-cell activation and differentiation. This is consistent with a 
model in which TCR induced pioneer factors act upstream of RA signaling.  
 
An emerging view – RARα, a central component of the enhanceosome 
This is the first study to compare genome wide RARα binding between different 
T helper cell lineages. In this study, we resolve paradoxical findings regarding 
the role of RA in Th17 differentiation and provide a molecular mechanism that 
explains previous studies. Our data provide a mechanistic basis for the 
pleiotropic roles for RA in the generation of Treg, Th1, Th17, and Th2 cells, 
suggesting that RA signaling is not lineage-specifying but rather acts to 
reinforce cell fate decisions through epigenetic mechanisms. There are two 
ways in which the ability of RARα to regulate gene expression in a cell type-
specific manner might be determined. One is that lineage specific factors recruit 
RARα, in trans, to pre-selected enhancers, where it acts as a co-factor, 
recruiting p300. The alternative is that RARα binding to RARE cis-binding sites 
is facilitated by lineage specific pioneer factors which determine the accessibility 
of RAREs within enhancer elements. Analysis of RARα binding in cells 
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expressing mutant RARα, lacking the DNA binding domain, could distinguish 
between these two possibilities. In either model, rather than specifying T-cell 
fate, RA enhances or stabilizes the actions of cytokines and transcription factors 
that guide T-helper cell programming.  
 
Based on the data above, we propose a model whereby RARα acts as 
the bridge between external environmental cues and the chromatin modifiers 
but its site of action and thus its specificity is determined by lineage-specific 
factors such as lncRNAs or lineage-defining transcription factors.  We 
hypothesise that lineage-specific factors may act as cofactors, either directing 
recruitment of RARα to permissive cell-type specific enhancers and/or licensing 
its action at sites of binding. An analogous role has been identified for the 
nuclear hormone androgen receptor where a number of lncRNAs were shown 
to license androgen receptor activity at enhancer regions (Hsieh et al., 2014). 
Temporal analysis of lncRNA expression during T helper cell specification has 
revealed cell-type specific patterns of expression, and highlighted a number of 
lncRNAs which are potential candidates for recruitment of RARα to lineage-
specific enhancers in T cells.  The feasibility of identifying the protein target of a 
candidate lncRNA has recently been reported, in studies of Xist, the lncRNA 
responsible for X-inactivation (McHugh et al., 2015). Investigation of potential 
interactions between RARα and lineage specific lncRNAs is an area of future 
work.  
 
Given that RARα has been implicated in the differentiation of a number 
of cell types, further studies are required to address the broader relevance of 
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our findings in cell lineages outside of the immune system. In support of a 
global role for RARα in the regulation of enhancers, a recent study identified 
RARα as part of a complex of transcription factors, that were critical for the 
regulation of oestrogen-receptor dependent enhancers.  In this study, RARα 
was recruited in trans to enhancer regions and the specificity of its actions at 
the genome level were determined by the oestrogen receptor. Given that 
RA/RARα is a highly conserved signaling pathway, which plays a critical role in 
regulating cell fate specification during embryogenesis and cell differentiation, it 
is perhaps not surprising that RA has been implicated in the fate of multiple T 
helper cell subsets.  
 
Retinoic acid – an immune morphogen? 
An additional aspect of RA regulation of T cell fate that remains to be 
addressed is the dose dependent effect of RA on T cell fate.  Similar to the 
morphogenic properties of RA during embryogenesis, the RA concentration 
sensed by naïve T-cells undergoing differentiation determines the dominant 
action of RA on T-cell fate.  Over the past few years, RA has achieved 
recognition as a morphogen, as it has become clear that synthesis and 
metabolism of RA is tightly controlled resulting in concentration dependent 
effects on target tissues (Casci, 2008). The preponderance of data from in vitro 
experiments in which dose titration comparisons were performed on Th1, Th2 
and Th17 polarisation suggest similar dose dependent effects of RA on 
haematopoietic cell fate (Iwata et al., 2003; Takahashi et al., 2012; Uematsu et 
al., 2008). The paradoxical effects of RA on opposing T-cell fates may therefore 
be explained by concentration dependent effects of RA, allowing T-cells to act 
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as an environmental sensor through the strength of its RA signal.  Further 
studies of RA gradients within lymphoid tissue as well as dose dependent 
effects of RA on RARα recruitment and p300 occupancy are required to test 
this hypothesis. However, the overriding message is that administration of RA 
either in vitro or to vitamin A replete hosts in vivo may not provide insight into 
the physiological actions of RA on T-cell responses.   
 
By blocking endogenous ligand signaling through RARα, rather than 
studying effects of added RA, my experiments sought to study physiological RA 
signaling, and did not address questions of concentration dependence. In vitro, 
the likely source of RARα agonists are RA and retinol present in serum. RXR 
agonists also activate the AF-2 domain of RARα. The endogenous ligands for 
RXR remain elusive. A number of molecules can bind to the RXR lipid binding 
pocket, including long chain unsaturated fatty acids such as omega-3 fatty acid 
docosahexaenoic acid (DHA) and other naturally occurring  polyunsaturated 
fatty acids (Lengqvist et al., 2004). Recent studies have shown that extensive 
metabolic reprogramming accompanies T helper cell differentiation, including 
changes in cellular lipid metabolism (Pearce et al., 2013). It is possible that a 
shift in metabolism generates intermediaries which serve as endogenous 
intrinsic RXR agonists signaling through RAR/RXR heterodimers. Intriguingly 
inhibition of fatty acid synthesis was shown to significantly impair Th17 
responses as well as Th1 and Th2 differentiation (Lochner et al., 2015). It is 
tempting to speculate that synthesis of RXR ligands by effector T cells during 
differentiation provides an autoregulatory pathway that sustains stable 




In summary, this work provides the first mechanistic framework for the 
regulation of T helper cell differentiation by RARα and sheds light on the 
fundamental principles by which enhancers are activated. By coupling RARα, a 
ligand-dependent transcription factor, which senses local changes in the 
microenvironment, to regulatory chromatin regions, RARα signaling contributes 
to dynamic changes in enhancers, regulating the stability and plasticity of T 
helper cell lineages. T cells represent an excellent model system for gaining 
insights into how extracellular cues can direct changes in chromatin structure 









C57Bl/6 (WT) were purchased from Charles River, UK. Cd4cre, and IfngeYFP 
(GREAT) mice were purchased from the Jackson Laboratory. Rosa26dnRara/dnRara 
mice were originally obtained from Dr. Sockanathana (Rajaii et al., 2008). F1 
progeny of Cd4cre and Rosa26dnRara/dnRara.breeders were first backcrossed onto 
the C57Bl/6 background from Jackson. Cd4creRosa26dnRara/dnRara (dnRara) mice 
were subsequently generated by crossing Cd4creRosa26dnRara and Rosa26dnRara 
breeders. dnRara mice have been described previously (Pino Lagos). Mice 
were bred and maintained at Charles River Laboratory, UK, or Kings College 
London, UK, in pathogen-free conditions. All animal experiments were 
conducted in accordance with the UK Animals (Scientific Procedures) Act 1986. 
C57Bl/6 OTII(dnRara), OTII and Rag1–/– mice were bred and maintained at the 
Rockefeller University specific pathogen free animal facility. All mice were used 
between 6-12 weeks of age. In each experiment, mice were littermate or gender 
and age matched. 
 
Reagents  
LLO190-201 was synthesised by PiProteomics and was >95% pure, as 
determined by HPLC. LLO:I-Ab monomers were provided by NIH Core Tetramer 
Facility. PE labeled LLO:I-Ab dextramers were synthesised by Immudex. 
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Recombinant Lm-2W strain was provided by Marc Jenkin’s Laboratory. LE540 
was purchased from Alpha Laboratories and resuspended in DMSO (Sigma) 
 
Naïve CD4+ T-cell isolation  
Spleens were harvested and mashed through a 70µm filter to obtain single cell 
suspensions. Cells were washed and enriched for CD4+ T cells using a CD4+ T-
cell negative selection kit (Miltenyi Biotec). Enriched cells were first blocked with 
1:100 anti-CD16/32 (2.4G2, eBioscience) and then labeled with a monoclonal 
antibody (mAb) cocktail containing anti-CD4 (RM4-5), anti-CD25 (PC61), anti-
CD62L (MEL14) and anti-CD44 (IM7). Naïve CD4+CD25negCD44loCD62Lhi T-
cells were purified by cell sorting using a FACSAria (BD). In experiments where 
eYFP reporter strains were used, eYFP+ cells were excluded. 
 
Antigen Presenting Cell (APC) isolation 
 T-cell depleted splenocytes were used as APCs. Spleens were harvested, cut 
into sections and perfused with collagenase (50mg/ml) and DNase I (20mg/ml) 
in warmed RPMI-1640. Tissues were placed in 5ml of perfusion media per 
spleen, and digested for 45 minutes at 37°C. Spleen fragments were then 
mashed through a 70µm filter to obtain single cell suspensions, washed with 
complete RPMI-1640 (cRPMI) medium containing 10% fetal bovine serum 
(FBS), 50 µM β-mercaptoethanol, 25mM HEPES, non-essential amino acids, 
glutamine and 100µg/ml penicillin/streptomycin. Cells were depleted of T cells 
using a CD3+ microbead selection kit (Miltenyi Biotec). Purity was checked and 
always exceeded 98%. Depleted cells were resuspended in cRPMI at 2 x106/ml 
and irradiated at 3000 rad.  
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Naïve CD4+ T-cell differentiation  
Naïve CD4+ T-cells were cultured for 3 days with irradiated T cell-depleted 
splenocytes at a ratio of 1:5 in the presence of 5 µg/ml of anti-CD3 (145-2C11) 
under Th0 cell conditions (IL-2 100 IU/ml, anti-IL-4 (11B11) and 10 µg/ml anti-
IFN-γ (XMG1.2); Th1 cell conditions (100 IU/ml of IL-2, 10 ng/ml of IL-12, and 
anti-IL-4 10 µg/ml); Th2 cell conditions (100 IU/ml of IL-2, 10 ng/ml of IL-4, anti-
IL-12 (C17.8), and 10 µg/ml of anti-IFN-γ (XMG1.2); or Th17 cell conditions, 
5 ng/ml TGF-β, 20 ng/ml IL-6, 10 ng/ml IL-1β, 10 µg/ml  of anti-IL-4, and anti-
IFN-γ).  Cells were expanded for an additional 3-4 days. IL-2 was supplemented 
in cultures every 2 days with the exception of Th17 cultures. Where indicated, 
10 ng/ml IFN-γ or 10 µg/ml anti-IFN-γ was added. In secondary repolarisation 
assays, where specified, LE540 (1 µM) or DMSO (vehicle control) was added to 
the media. IL-2 was from Miltenyi and other cytokines were from R&D Systems. 
Anti-CD3 was from BioXcell and other antibodies were from BD Biosciences. All 
cell cultures were performed in complete RPMI. 
 
Flow Cytometry 
For analysis of cytokine production, cells were restimulated with phorbol 12-
myristate 13-acetate (PMA) 100 ng/ml and ionomycin 500 ng/ml in the presence 
of monensin (1µl/ml Biolegend) for 4-5 h at 37oC in a tissue culture incubator 
(37oC/5%CO2). Cell surface staining was carried out in PBS with 2% FBS. For 
live cell analysis or cell sorting, dead cells were excluded by staining with 
SYTOX blue (Invitrogen). For intracellular staining, cells were first stained with 
LIVE/DEADTM Fixable Violet or near IR Dead Cell Stain (Invitrogen) in PBS and 
blocked with 1:100 anti-mouse CD16/32, followed by staining for cell-surface 
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markers and then resuspended in fixation/permeabilisation solution 
(Cytofix/Cytoperm kit or Transcription Factor Buffer kit; BD Biosciences). 
Intracellular staining was carried out in accordance with the manufacturer’s 
instructions. The fluorescent-dye-conjugated antibodies used were obtained 
from BD-Biosciences: anti-CD4 (RM4-5), anti-CD3 (145-2C11); anti-CD62L 
(MEL14), anti-CD44 (IM7), anti-CD8α (53-6.7), anti-IL-17A (TC11-18H10), anti-
IFN-γ (XMG1.2), anti-IL-4 (11B11), anti-RORγt (Q31-378); eBioscience: anti-
Foxp3 (FJK-16a), anti-T-bet (eBio4B10) or Biolegend: anti-CD25 (PC61). The 
following isotype controls were included in staining panels where indicated: rat 
IgG1, rat IgG2a, mouse IgG2a, and mouse IgG1. AccuCheck counting beads 
(Invitrogen) were added to samples for calculation of absolute cell numbers.   
Data were collected with a LSR Fortessa (BD) and results were analyzed with 
FlowJo software (Tree Star).  
 
PhosphoSTAT staining 
Intracellular phosphorylated STAT proteins were stained with Phosflow Lyse/Fix 
Buffer, and Phosflow Perm Buffer III (BD Biosciences) according to the 
manufacturer’s protocol. The following antibodies were used for detection of 
phosphorylated STAT proteins: anti-pSTAT1 (pY701), anti-pSTAT4 (pY693) 
and anti-pSTAT3 (pY705). All antibodies were obtained from BD-Biosciences. 
 
Chromatin immunoprecipitation (ChIP) 
Prior to harvesting, dead cells were depleted from culture with the Dead Cell  
Removal kit (Miltenyi Biotec) as per manufacturer’s protocol. 20-60 million Th1 
polarised cells from WT and dnRara mice were fixed, washed and snap-frozen 
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according to the Cell Fixation protocol from Active Motif. Cells were 
resuspended in complete RPMI and fixed with the addition of 1/10 volume of 
freshly prepared Formaldehyde solution containing 11% Formaldehyde 
(Sigma), 0.1M NaCl (Sigma), 1mM EDTA (Sigma0 and 1M HEPES (Affymetrix). 
Cells were agitated for 15 minutes at room termperature. 1/20 volume of 2.5M 
Glycine solution was added to stop the fixation and cells were incubated for 5 
minutes. All subsequent steps were performed on ice or at 4oC. Cells were 
washed once with PBS 0.5% Igepal and a second time with PBS-Igepal 
containing 1mM Phenylmethanesulfonyl fluoride. Cells were pelleted, snap 
frozen in liquid nitrogen and stored at -80oC. 
  
Chromatin was isolated by the addition of lysis buffer, followed by disruption 
with a Dounce homogenizer. Lysates were sonicated and the DNA sheared to 
an average length of 300-500 bp. Genomic DNA (Input) was prepared by 
treating aliquots of chromatin with RNase, proteinase K and heat for de-
crosslinking, followed by ethanol precipitation. Pellets were resuspended and 
the resulting DNA was quantified on a NanoDrop spectrophotometer. 
Extrapolation to the original chromatin volume allowed quantitation of the total 
chromatin yield. An aliquot of chromatin was precleared with protein A agarose 
beads (Invitrogen). Following immunoprecipitation with specified antibodies, 
complexes were washed, eluted from the beads with SDS buffer, and subjected 
to RNase and proteinase K treatment. Crosslinks were reversed by incubation 
overnight at 65 C, and ChIP DNA was purified by phenol-chloroform extraction 
and ethanol precipitation and used for the preparation of Illumina sequencing 




Quantitative PCR (qPCR) reactions were carried out in triplicate on specific 
genomic regions using SYBR Green Supermix (Bio-Rad).  See Table S5 for 
Primer details. The resulting signals were normalized for primer efficiency by 
carrying out qPCR for each primer pair using Input DNA. By using standards of 
known quantities of DNA it was possible to calculate the number of genome 
copies pulled down for each of the sites tested, and thus to calculate the copies 
pulled down per starting cell number, presented as ‘Enrichment’. For RARα 
ChIP qPCR a gene desert on chromosome 6 (Untr6) was used for a negative 
control site (Active Motif Catalog No: 71011). 
 
ChIP Sequencing (Illumina) 
Illumina sequencing libraries were prepared from the ChIP and Input DNAs 
using standard procedures and libraries were sequenced on HiSeq 2500 




CHAPTER 2 Methods: 
 
Cell Proliferation analysis  
Cells were labeled at a concentration of 1x106cells/ml with 5µM CellTraceTM 
Violet (Invitrogen) diluted in PBS for 20 min at 37oC/5%CO2. Labeling was 
quenched with 5X volume of complete RPMI. Cells were incubated for 
10minutes prior to washing and resuspending in complete RPMI. Cells were 
stimulated under Th1 conditions as detailed above. 
 
TAT-Cre transduction 
Sort purified naïve CD4+ T cells were differentiated under Th1 conditions. After 
5 days, cells were washed twice in serum free medium prior to treatment with 
50 µg/ml TAT-Cre (Millipore) or medium alone (mock treatment). Cells were 
incubated at 37°C for 45 minutes. The reaction was quenched with equal 
volumes of medium containing 20% FBS followed by further washing. Cells 
were expanded for 2 days in cRPMI with IL-2 (50 IU/ml), followed by 
retreatment with TAT-Cre or media as before. Cells were then restimulated 
under Th1 cell conditions for 3 days and expanded for a further 2 days prior to 
analysis. IL-2 (50IU/ml) was supplemented in cultures every 2 days.  
 
Western Blotting 
Differentiated Th1 cells were lysed in RIPA buffer supplemented with protease 
inhibitors. Lysates were electrophoresed on 10% gels (Biorad), transferred to 
nitrocellulose and blotted with anti-STAT4 or anti-actin followed by anti-rabbit-




L. monocytogenes (actA LM-2W) infection  
L. monocytogenes was grown overnight in LB broth supplemented with 
chloramphenicol (20µg/mL), in a shaker at 370C, 250rpm. After 12-16hrs, the 
bacteria were sub-cultured after a 1:100 split and grown to an OD600 of 
~0.1.  Bacterial cells were harvested at 5,000 g for 10 min and resuspended to 
5x106 cfu/ml in room temperature PBS. Mice were infected intra-venously via 
tail vein injection with 1 x 106 cfu. 
 
L. monocytogenes analysis 
For FACS analysis, single cell suspensions of spleens from L.monocytogenes 
infected mice were prepared as described above. Red blood cells were lysed in 
ACK for 2 minutes at room temperature. Single cell suspensions were enriched 
for CD4+ T-cells with a CD4+ T-cell negative selection microbead kit (Miltenyi 
Biotec) and stained with PE labeled, LLO:I-Ab dextramer (Immudex) in complete 
RPMI for 1 h at 37oC/5%CO2. Cells were then transferred to ice and stained 
with cell surface antibodies. The antibodies used were obtained from 
Ebioscience: anti-CD3 (145-2C11), anti-B220 (RA3-682), anti-CD11c (N418), 
anti-CD11b (M170), anti-F4/80 (BM8), or BD Bioscience: anti-CD4 (RM4-5) 
anti-CD44 (IM7) anti-CD8α (53-6.7) or Biolegend: anti-IL6-Rα (D7715A7). 
 
In vitro recall to L. monocytogenes  
Single cell suspensions of spleens from L.monocytogenes infected mice were 
prepared as described above. For analysis of cytokine production, supernatants 
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were collected from splenocytes restimulated with LLO peptide (PiProteomics) 
at 10 µg/ml for 24 h. For analysis of intracellular cytokines, splenocytes were 
stimulated with LLO peptide for 6 h in the presence of monensin. Intracellular 
cytokine staining was performed as described above. 
 
Luminex Immunoassays 
Cytokine levels in supernatants were measured using a multiplex bead-based 
assay (Bio-Rad Laboratories) in a Luminex FlexMap3D System (Luminex 
Corporation) as per the manufacturer’s instructions. 
 
Real-Time Quantitative PCR. 
Total RNA was extracted from cells with RNeasy Mini kit (Qiagen) and cDNA 
was synthesised with Qscript RT kit (Quanta). Quantitative gene expression 
analysis was peformed using Taqman primer probe sets (Applied Biosystems), 




For each sample the 50bp SE reads in FastQ format from the sequencer were 
aligned to the mouse reference genome (mm10) using Novoalign v2.07.11 
(http://www.novocraft.com). The resulting alignment file was converted to BAM 
format using samtools (http://samtools.sourceforge.net/) and the PCR 
duplicates were removed using picard tools (http://picard.sourceforge.net). Only 
uniquely mapped reads from each sample were selected for further analysis. 
Significantly enriched regions from each sample were identified with MACS 
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v2.0.10 (Feng et al., 2011; Zhang et al., 2008) (with q=0.10) using the input 
sample for background correction. In some instances peaks were identified by 
visual inspection and confirmed by ChIP qPCR. In case of H3K4me1 and 
H3K27me3 samples, “--broad” setting was used to merge nearby enriched 
regions. For visualization purposes, the input signal was subtracted from each 
ChIP sample and was converted into bigWig format using “bedGraphToBigWig“ 
utility from UCSC tools (http://genome.ucsc.edu/util.html). The identified 
significantly enriched regions were annotated to find the associated genes 
using “FindNeighbouringGenes” utility from USeq package 
(http://useq.sourceforge.net/). Associated genes represent the closest 
transcriptional start site from the centre of the peak. 
 
Microarray data  
Total RNA was extracted from cells lysed in Trizol LS reagent (Life 
Technologies). RNA quality was assessed with an Agilent 2100 Bioanalyzer 
(Agilent Technologies) and quantified with the Nanodrop ND-1000 UV-
spectrophotometer (NanoDrop Technologies). 
Transcriptome in IFN-γ+ (eYFP+) CD4+ T-cells 
Naïve CD4+ T-cells from dnRara-IFN-γeYFP or littermate control IFN-γeYFP 
reporter mice were cultured under Th1 conditions. On day 7 of culture, following 
restimulation with PMA and ionomycin, eYFP+ cells were sorted and total RNA 
was extracted for transcriptional profiling using Affymetrix Mouse Gene 2.0 ST 
arrays. Pre-processing and statistical analysis of gene expression data were 
done using Partek Genomics Suite 6.6. CEL files were imported and expression 
intensities were summarised, normalised and transformed using Robust 
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Multiarray Average algorithm. Two additional samples from eYFP+ dnRara or 
wild-type cells sorted without prior restimulation were included in the 
normalisation. These samples were not included in the analysis of differentially 
expressed genes. P values <0.05 and fold change in expression ≥ 1.5 or ≤ -1.5 
were considered significant. 
Transcriptome in Th1 differentiated cells 
Sorted naïve CD4+ T-cells from dnRara or WT mice were polarised under Th1 
conditions. On day 6 of culture cells were harvested and total RNA was 
extracted for microarray study or ChIP. RNA isolation, microarray and data 
processing performed by Miltenyi Biotec. Transcriptome analysis was 
performed using Agilent Whole Mouse Genome Oligo Microarrays 8X60K in 
accordance with manufacturer’s protocol. Data analysis was performed using 
R/bioconductor and software packages therein (http://www.R-project.org ; 
http://www.bioconductor.org) or MS-Office Excel (Microsoft Inc.). Background 
corrected intensity values were normalized between arrays using quantile 
normalization. Quality controls include comparison of intensity profiles and a 
global correlation analysis. Differentially expressed genes were identified by 
statistical group comparisons on normalized (background corrected and 
quantile normalized) log2 transformed fluorescence intensities using Student´s 
t-test (two-tailed, equal variance). Reporters showing a p-value ≤ 0.05 and a 
median fold-change in expression ≥ 1.5 or ≤ -1.5 were considered as reliable 
candidates for altered gene expression. In addition, at least two of the replicate 
samples in the group with higher expression were required to have detection p-
values ≤ 0.01. 
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CHAPTER 3 Methods 
 
Th17 cells for ChIP 
Th17 cells were harvested on day 5 of culture and prepared as outlined above 
in ‘General Methods – ChIP’. For analysis of Th17 cells on day 3 of culture, 
cells were Fc blocked and labelled with anti-CD4 (RM4-5) and SYTOX to 
exclude dead cells. Live CD4+ T cells were purified by cell sorting using a 
FACSAria (BD). Cells were then fixed in accordance with Active Motif’s 
protocol, as detailed above. 
 
Microarray data 
Transcriptome data from dnRara and WT Th1 cells generated in Chapter 2 was 
analysed in R/bioconductor using the limma program package. Background 
correction and quantile normalization was performed. Control probes and low 
expression probes as well as lincRNAs and probes with unknown annotations 
were filtered. Differentially expressed genes (fold change >1.5, FDR < 0.05) 
were identified using limma. To determine enrichment of genes up- or 
downregulated in dnRara Th1 cells at RARα bound promoters and enhancers, 
we first generated ‘gene-sets’ based on genes containing RARα peaks at 
promoter regions (-4kbp to +500bp) (Pro), enhancers (E) or both. Enhancers 
were associated to the gene closest to the genomic region. Gene sets were 
filtered by genes that are measured by the Agilent array. Fisher’s exact test was 




Identification of T helper cell subset signature genes  
Publicly available gene expression data for Th17, Th1, Th2 and iTreg cells from 
(Wei et al., 2011) was downloaded and analysed using the default settings in 
Partek Genomics Suite 6.6. To avoid spurious fold changes due to low 
expression values, a small constant (c=0.25) was added to the normalized 
RPKM values. For each subset, we identified genes that were over-expressed 
compared to all other cell subsets, with a fold change ≥ 1.5 and p value < 0.05. 
200 genes were selected at random (excluding genes in the T helper cell 
subset specific lists). The TSSs of these Th-cell-subset-specific and random 
genes were selected using RefSeq annotation and extended ±20kb. Normalized 
tag intensity of Th1 RARα binding was calculated in these extended regions 
from all cell types and plotted using R. A two-tailed student t-test was performed 
to calculate the significance of enrichment. 
For analysis of Th17-specific RARα bound regions we used a set of literature-
curated Th17 genes (Gagliani et al., 2015). 
 
Functional enrichment analysis of bound or affected genes  
Th1-specific RARα binding sites were identified as detailed above. The 
identified regions were annotated to find the associated genes using 
“FindNeighbouringGenes” utility from USeq package 
(http://useq.sourceforge.net/). KEGG enrichment for this gene set was carried 
out using Web-Based Gene Set Analysis Toolkit (Webgestalt) (Zhang et al., 
2005). GO enrichment was performed with PANTHER using annotations based 
on experimental evidence (Thomas, 2003). Functional enrichment analysis of 
genes containing cell-type-specific RARα binding sites or differentially 
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expressed genes in dnRara Th1 cells was performed using annotations and 
datasets from the MSigDB database (Subramanian et al., 2005).  
 
ChIP-seq analysis 
The SE reads in FastQ format from each sample were aligned to the mouse 
reference genome (mm10) using Novoalign v2.07.11 
(http://www.novocraft.com). The resulting alignment file was converted to BAM 
format using samtools (http://samtools.sourceforge.net/) and the PCR 
duplicates were removed using picard tools (http://picard.sourceforge.net). Only 
uniquely mapped reads from each sample were selected for further analysis. 
Significantly enriched regions from each sample were identified with MACS 
v2.0.10  (Feng et al., 2011; Zhang et al., 2008) using a q value of 0.05. The 
control library for peak-calling was the input DNA performed under Th1 
conditions without antibody for background correction. T-bet binding from 
publicly available data in (Gökmen et al., 2013) was similarly analysed with its 
corresponding input. For H3K27me3 libraries , “--broad” setting was used to 
merge nearby enriched regions and the q-value was set to 0.10. Intensities of 
all binding sites are normalized to the number of uniquely mapped reads after 
PCR duplicate removal. For visualization purposes the input signal was 
subtracted from each ChIP sample and each file was converted into bigWig 
format using “bedGraphToBigWig“ utility from UCSC tools 
(http://genome.ucsc.edu/util.html). The y-axis in all gene tracks is the 
normalised read count. 
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The identified significantly enriched regions were annotated to find the 
associated genes using “FindNeighbouringGenes” utility from USeq package 
(http://useq.sourceforge.net/). 
 
Reproducibility of p300 and RARα peaks  
The genome was divided into 5kb non-overlapping windows and the normalized 
tag intensity from each replicate was calculated for each window. All windows 
with zero intensity in both replicates were removed and all remaining windows 
were used to plot a correlation between the two replicates. Function “cor” in R 
was used to compute the r2 value. 
 
Genomic distribution of RARα binding 
The genomic distribution of RARα binding sites was performed using all the 
sites with a q value ≤ 0.05 identified by the MACS peak caller. The distribution 
was calculated with “assignGenomeAnnotation” executable within Homer 
package using RefSeq annotation for the mouse genome assembly mm10. 
 
Delineation of enhancers 
Peak calling on duplicates of p300 WT Th1 cells was performed. Peaks that 
were not common between the two libraries were discarded.  All regions that did 
not overlap with promoter-associated peaks (-4kbp to +500bp of the TSS) were 
included in the downstream analysis. We then selected regions which overlap 
with H3K4me1 peaks. To generate the final catalogue of enhancers we further 
filtered regions based on H3K4me3 intensity to retain regions with no H3K4me3 
or low levels of intensity (H3K4me3low). To define H3K4me3low regions we first 
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selected all H3K4me3 regions that overlap with p300 and H3K4me1 peaks 
outside of promoters and plotted a histogram of the H3K4me3 fold changes at 
these sites. We observed a bi-modal distribution of H3K4me3 levels. From the 
distribution we considered H3K4me3 regions with a fold change ≥30 as regions 
of high H3K4me3 intensity. Removing these regions resulted in 10,511 regions 
that were considered to be Th1 enhancers. These regions were used for the 
rest of the analysis unless otherwise stated. Enhancers overlapping with RARα 
peaks are termed ‘RARα bound’ enhancers and others as ‘RARα negative’ 
enhancers. Overlapping peaks were identified using “intersectBed” from 
Bedtools. 
 
Identification of Super-enhancers (SEs) and cell-type specific SEs. 
Genomic co-ordinates for SE domains in Th1, Th2 and Th17 cell types were 
downloaded from (Vahedi et al., 2015). The regions were subjected to liftOver 
to convert to mm10 coordinates. Cell-type-specific super-enhancer regions are 
defined as regions in one cell condition that have no overlap with any of the 
other cell conditions, using “intersectBed” from Bedtools with a 1-bp overlap 
method. The Th1 specific SE regions that overlap with any of the RARα binding 
sites are defined as RARα-bound Th1 SEs 
 
Binding distribution across a set of coordinates 
To check for differences in binding intensity between samples at certain binding 
sites, the normalized tag intensity of a sample was plotted from the centre of a 
binding site and extended on either side by 5kb. “sitepro” from CEAS package  
was used to plot the intensities of uniquely mapped reads after removing PCR 
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duplicates. For analyais of p300 intensity at Th1 super-enhancers, we used a 
scale of ±50kb from the centre of each super-enhancer. 
 
Motif Analysis 
De novo motif analysis was carried out using the HOMER package. Motifs were 
searched on the specified peak summit ± 200bp. An equal number of 
background regions of the same length were randomly selected from the mm10 
genome using “randomBed” from Bedtools. In analyses were we compared 
enrichment of motifs in Th1 specific RARα bound enhancers, Th1 specific 
RARα binding sites outside of enhancers were used for background regions. 
We searched for de novo motifs (with homer2 executable) for lengths 8 – 14bp 
using the following parameters (-mis 1 -S 50). HOMER initially identifies oligos 
of a particular length that are significantly enriched (using binomial distribution) 
in the target sequences compared to the background. The significant oligos are 
then converted to position weight matrices. We then compared these 
significantly enriched PWM’s to a dataset of previously known transcription 
factor PWM’s provided within the HOMER collection using “compareMotifs.pl” 
for each length analyzed. This returns a best identified match from the known 
transcription factors with a score that relates the identified de novo motif to the 
previously known motif.  
 
Identification of cell-type-specific RARα peaks  
Any given RARα binding site is called as specific for a cell type if RARα peaks 
were observed in one cell type with no overlaps with binding sites in the other 
cell types. On similar lines we also identified regions that are common between 
! 114!
pairs of cell types or common to all samples. We used “intersectBed” from 
Bedtools while using “-v” flag to fetch cell-type-specific and common binding 
sites. The heatmap showing the specific and common regions from naïve, Th1 
and Th17 cells was plotted using ngsplot with “-GO none -SC global “ 
parameters.  
 
Overlap of LDTFs and RARα at Th1 enhancers  
We used the RARα and T-bet binding sites identified by our analysis detailed 
above. For STAT1, STAT4 we downloaded the publicly available binding 
regions from (Vahedi et al., 2012) and converted to mm10 using liftOver utility 
from UCSC. For each factor we first removed any binding sites that did not 
overlap with our Th1 enhancer regions. We then computed the overlap between 
the remaining binding sites. The venn-diagram was plotted using “diffBind”. 
 
Overlap of RARα binding sites with Foxp3 binding sites 
We downloaded the publicly availably binding regions for Foxp3 in Treg cells 
(Samstein et al., 2012) and converted to mm10. We then computed the overlap 
with all RARα-bound Th1 enhancers and Th1-specific RARα binding sites.  
 
Regression analysis for p300 intensity 
To determine the contribution of different TFs to p300 binding at Th1 
enhancers, we performed linear modelling to model the intensity of p300 in the 
presence or absence of a given TF. To do this we initially calculated the read 
intensities of p300 in each of the previously described enhancer regions and 
presence or absence of a factor at each region as binary (0 or 1 for absent and 
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present respectively). A matrix representing log transformed p300 intensities 
and the binary representations of factors was prepared and the “lm” function in 
R was used to calculate the significance of each factors role in explaining p300 
intensity, modelling log(p300) as a function of the presence or absence of the 
TFs. We considered all individual terms, as well as all two-way interaction terms 
for pairwise combinations of TFs.  
 
Statistical analysis 
Statistical significance of the overlap between two groups of genes was 
calculated using the hypergeometric probability formula.  
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